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(57) ABSTRACT 
The present disclosure relates generally to bacterial NADH 
oxidases and, more particularly, to novel NADH oxidases 
obtained from Lactobacillus plantarum, and derivatives 
thereof that demonstrate enzymatic activity for NADH, 
NADPH, or both NADH and NADPH. The compositions 
comprising an NAD H oxidase obtained from L. plantarum or 
derivatives thereof include: isolated enzymes; recombinantly 
produced enzymes and derivatives thereof, as well as cata-
lytically active portions thereof; nucleic acids encoding an 
NADH oxidase obtained from L. plantarum, derivatives 
thereof, and portions thereof. The methods of the present 
invention include isolation ofNADH oxidases obtained from 
L. plantarum, derivatives thereof, and portions thereof, and 
methods for enzymatic reactions comprising NADH oxidase 
obtained from L. plantarum, including the production of 
enantiomer-enriched organic compounds. 
13 Claims, 3 Drawing Sheets 
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COMPOSITIONS AND METHODS FOR 
USING NADH OXIDASES 
2 
from Thermoanaerobium brockii for both NADH and 
NADPH and with (R)-ADH from L. brevis for NADPH; this 
coupled-substrate approach, however, suffers from equilib-
rium limitations. The more common coupled-system CROSS-REFERENCE TO RELATED 
APPLICATIONS 
This application claims, under 35 U.S.C. § 119( e ), the ben-
efit ofU.S. Provisional Application Ser. No. 61/265,915, filed 
2 Dec. 2009, and U.S. Provisional Application Ser. No. 
61/383,858, filed 17 Sep. 2010, the entire contents and sub-
stance of which are hereby incorporated by reference as if 
fully set forth below. 
5 approach, employing a separate second enzyme for regenera-
tion, has been developed for reducing oxidized cofactors, 
NAD+ or NADP+, to NADH or NADPH. By far the most 
successful regeneration enzyme is formate dehydrogenase 
(FD H) for regeneration to either NAD PH or NAD H, the latter 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH 
10 even up to industrial scale. Other options include the use of 
glucose 6-phosphate dehydrogenase (to NADPH only) or of 
glucose dehydrogenase, GluDH. For the opposite direction of 
regeneration, however, from NADPH to oxidized cofactors 
NAD+ or NADP+, no universally accepted system exists. 
15 For reductive reactions with dehydrogenases or for 
This invention was made with U.S. Govermnent support 
under Grant No. 2 R44AI65127-02 awarded by the National 
Institutes of Health. The U.S. Govermnent has certain rights 
in the invention. 
BACKGROUND OF THE INVENTION 
1. Technical Field 
20 
The various embodiments of the present disclosure relate 25 
generally to bacterial NADH oxidases and, more particularly, 
to NADH oxidases obtained from Lactobacillus plantarum, 
and derivatives thereof that demonstrate enzymatic activity 
for NADH, NADPH, or both NADH and NADPH. 
monooxygenases, NADPH has to be regenerated from 
NADP+. For this problem, the system formate dehydrogenase 
(FDH)/formate is now used almost universally, which is 
shown below: 
HCOOH+NAD+ ~NADH+H• +C02 (1) 
FDH functions as a universal regeneration enzyme in tandem 
with dehydrogenases catalyzing extremely enantioselective 
reduction reactions. 
There are some currently known NADH oxidases that are 
able to oxidize NADH to NAD+ with simultaneous reduction 
of 0 2 to either H20 2 or H20. Four-electron reduction to 
benign H20 is preferred over two-electron reduction to H20 2, 
which, even in small amounts, can deactivate either enzyme 
2. Description of Related Art 30 of the production-regeneration cycle. Addition of catalase as 
a possible remedy, to degrade the H20 2, increases complexity 
of the system to the point where three enzymes have to be 
coupled and adjusted as to their activity over time. 
Enantiomerically pure compounds (EPCs ), especially 
amino and hydroxy acids as well as alcohols, amines, and 
lactones are increasingly useful in the pharmaceutical, food, 
and crop protection industries as building blocks for novel 
compounds not accessible through fermentation as well as for 35 
asymmetric synthesis templates. For example, interest in the 
production of L-nucleosides such as L-ribose, L-mannose 
and L-glucose has arisen for a number ofL-nucleoside-based 
pharmaceutical compounds. Emtricitabine and Clevudine are 
some examples of pharmaceutical compounds that are based 40 
on L-nucleosides, and a number of these pharmaceuticals are 
currently approved or in clinical trials. 
One advantageous route to a wide variety ofEPCs is the use 
of dehydrogenases, to afford either reduction of keto com-
pounds or oxidation of alcohol or amine groups. The reper- 45 
toire of dehydrogenases useful for synthesis ofEPCs encom-
passes alcohol dehydrogenases (ADHs), D- and L-lactate 
dehydrogenases (LDHs), D- or L-hydroxyisocaproate dehy-
drogenases (D- or L-HicDHs ), or amino aciddehydrogenases 
such as leucine dehydrogenase (LeuDH), phenylalanine 50 
dehydrogenase (PheDH), or glutamate dehydrogenase 
(GluDH). Monooxygenases have been used to synthesize, 
regio- and enantioselectively, lactones from cyclic ketones 
useful in the flavor and fragrance industries. 
For oxidative reactions requiring regeneration of NADP+ 
from NADPH, prior to the present invention, no universal 
cofactor regeneration system was known. Alcohol dehydro-
genase (ADH) itself can be utilized to catalyze both the oxi-
dative production reaction as well as the reductive regenera-
tion reaction by adding isopropanol which is oxidized to 
acetone, but such a scheme tends to be equilibrium-limited 
and plagued by deactivation of ADH. Both the ADH and the 
lactate dehydrogenase (LDH) systems cannot take NADPH, 
in contrast to glutamate dehydrogenase (GluDH), which has 
been utilized to reduce a-ketoglutarate to L-glutamate. 
NADH oxidases from thermophiles have been employed 
which regenerate NAD+ from NADH by reducing 0 2 to 
H202. 
What is needed are enzymes that regenerate NADH and 
NADPH to oxidized cofactors NAD+ and NADP+ and syn-
thesis methods that employ such enzymes alone or in coupled 
reactions. What is also needed are enzymes that perform the 
oxidation ofNADH to NAD+ with the concomitant reduction 
of molecular oxygen to water as a solution to the cofactor 
regeneration problem from NADH to NAD+. Further, what is 
55 needed are methods for efficiently isolating the enzymes. Dehydrogenases and monooxygenases require nicotina-
mide-based cofactors, such as NAD+ and NADP+ or their 
reduced equivalents, NADH and NADPH, to function. Eco-
nomic use of dehydrogenases and cofactor necessitates 
cofactor regeneration. Cofactor costs, for example, $31 per 
gram for NAD+ and $232 per gram of NADP+, have to be 60 
considered and having cofactors regenerated would cut costs 
by the turnover number for such cofactors, between 100 and 
up to 600,000. 
Cofactor regeneration with alcohol dehydrogenases can be 
performed by using the same enzyme for in-situ substrate 65 
conversion and cofactor regeneration, usually employing iso-
propanol as co-substrate, as demonstrated with (S)-ADH 
BRIEF SUMMARY OF THE INVENTION 
Various embodiments of the present invention are directed 
to bacterial NADH oxidases and, more particularly, to NADH 
oxidases obtained from Lactobacillus plantarum, and deriva-
tives thereof that demonstrate enzymatic activity for NADH, 
NADPH, or both NADH and NADPH. A composition of the 
present invention comprises an isolated bacterial NAD H oxi-
dase, which is obtained from Lactobacillus plantarum. This 
isolated bacterial NADH oxidase can comprise the amino 
acid sequence of SEQ ID NO: 1, which is encoded by a 
US 8,530,213 B2 
3 
nucleic acid sequence comprising SEQ ID NO: 2. Such a 
nucleic acid sequence can be incorporated into a vector, 
which may in turn be introduced into a host cell. 
4 
regenerate NAD+. In another embodiment of the present 
invention, isolated bacterial NADH oxidases derived from 
Lactobacillus plantarum can regenerate NADP+. In yet 
another embodiment of the present invention, isolated bacte-
rial NADH oxidases derived from Lactobacillus plantarum 
can regenerate both NADP+ and NAD+. The isolated bacte-
rial NADH oxidases derived from Lactobacillus plantarum, 
which regenerates NADP+ and NAD+, can comprise an 
amino acid sequence selected from the group consisting of 
In one embodiment of the present invention, isolated bac-
terial NADH oxidases obtained from Lactobacillus plan-
tarum can regenerate NAD+. In another embodiment of the 
present invention, isolated bacterial NADH oxidases derived 
fromLactobacillus plantarum can regenerate NADP+. In yet 
another embodiment of the present invention, isolated bacte-
rial NADH oxidases derived from Lactobacillus plantarum 
can regenerate both NADP+ and NAD+. 
For example, an isolated bacterial NADH oxidases derived 
fromLactobacillus plantarum, which regenerates NADP+ or 
both NADP+ and NAD+, comprises SEQ ID NO: 1, wherein 
SEQ ID NO: 1 comprises at least one amino acid mutation 
that facilitates enzymatic activity towards NADPH. A nucleic 
acid sequence that encodes a NADH oxidases derived from 
Lactobacillus plantarum, which regenerates NADP+ or both 
NADP+ and NAD+ can hybridize under stringent conditions 
to the nucleic acid comprising SEQ ID NO: 2. 
10 SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 
8, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID 
NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, or SEQ ID NO: 17. 
In an exemplary embodiment, the second enzyme selective 
for a nicotinamide-based cofactor comprises SEQ ID NO: 8 
15 or SEQ ID NO: 18. 
Other aspects and features of embodiments of the present 
invention will become apparent to those of ordinary skill in 
the art, upon reviewing the following description of specific, 
exemplary embodiments of the present invention in conjunc-
20 tion with the accompanying figures. 
An isolated bacterial NAD H oxidases derived from Lacto-
bacillus plantarum, which regenerates NADP+ or both 
NADP+ and NAD+, can comprise an amino acid sequence 
selected from the group consisting of SEQ ID NO: 3, SEQ ID 
NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 9, SEQ 25 
IDNO: 11, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 15, 
SEQ ID NO: 16, and SEQ ID NO: 17. In an exemplary 
embodiment, an isolated bacterial NADH oxidases derived 
fromLactobacillus plantarum, which regenerates NADP+ or 
both NADP+ and NAD+, can comprise an amino acid 30 
sequence of SEQ ID NO: 8 or SEQ ID NO: 16 
Examples of nucleic acid sequences that encode a NADH 
oxidases derived from Lactobacillus plantarum, which 
regenerates NADP+ or both NADP+ and NAD+ that can 
hybridize under stringent conditions to the nucleic acid com- 35 
prising SEQ ID NO: 2, include, but are not limited to nucleic 
acid sequences selected from the group consisting of SEQ ID 
NO: 5, SEQ ID NO: 7, SEQ ID NO: 10, SEQ ID NO: 13, and 
SEQ ID NO: 18. In an exemplary embodiment, an isolated 
bacterial NADH oxidases derived from Lactobacillus plan- 40 
tarum, which regenerates NADP+ or both NADP+ and 
NAD+, can be encoded by a nucleic acid sequence compris-
ing SEQ ID NO: 10 or SEQ ID NO: 18. 
Another aspect of the present invention comprises a 
method of producing an enantiomer-enriched organic com- 45 
pound, comprising: reacting a substrate with a first enzyme 
selective for producing an enantiomer, wherein the first 
enzyme requires a oxidized nicotinamide-based cofactor for 
catalytic activity; producing the enantiomer, its oxidized 
counterpart, and a reduced nicotinamide-based cofactor; and 50 
oxidizing the reduced nicotinamide-based cofactor with a 
second enzyme selective for a nicotinamide-based cofactor. 
In one embodiment of the present invention, the enantiomer 
comprises an L-nucleoside, and the second enzyme selective 
for a nicotinamide-based cofactor comprises a NADH oxi- 55 
dase obtained from Lactobacillus plantarum. In another 
embodiment of the present invention, the second enzyme 
selective for a nicotinamide-based cofactor can catalyze more 
than 113,000 turnovers per active site. In yet another embodi-
ment of the present invention, the second enzyme selective for 60 
a nicotinamide-based cofactor can catalyze more than 100, 
000 turnovers per active site in the absence of an externally 
added reducing agent. 
In this method, the NADH oxidase obtained from Lacto-
bacillus plantarum can comprise SEQ ID NO: 1. In one 65 
embodiment of the present invention, isolated bacterial 
NADH oxidases obtained from Lactobacillus plantarum can 
BRIEF DESCRIPTION OF DRAWINGS 
FIG.1 is a schematic illustrating the conversion of ribitol to 
L-ribose through mannitol-1-dehydrogenase from Apium 
graveolens complemented with NADH cofactor regeneration 
using NADH oxidase. 
FIG. 2 illustrates the activity profile of NADH oxidase 
from Lactobacillus plantarum V (NOX5) at different pHs. 
FIG. 3 illustrates the activity profile of NOX5 at various 
temperatures. 
FIG. 4 is a T5030 plot that demonstrates stability ofNOX5 
by incubating at different temperatures. 
FIG. 5 is a plot of kinetics using different models: non-
linear Michaelis-Menten, Lineweaver-Burk, Eadie-Hofstee, 
and Hanes-Woolf. 
FIG. 6 graphically depicts a Hanes-Woolf plot of NAD+ 
inhibition pattern ofNOX5. 
DETAILED DESCRIPTION OF THE INVENTION 
Throughout this description, various components can be 
identified as having specific values or parameters, however, 
these items are provided as exemplary embodiments. Indeed, 
the exemplary embodiments do not limit the various aspects 
and concepts of the present invention as many comparable 
parameters, sizes, ranges, and/or values can be implemented. 
The terms "first," "second," and the like, "primary," "second-
ary," and the like, do not denote any order, quantity, or impor-
tance, but rather are used to distinguish one element from 
another. Further, the terms "a," "an," and "the" do not denote 
a limitation of quantity, but rather denote the presence of "at 
least one" of the referenced item. 
In general, NADH oxidases (E.C. 1.6.-.-) catalyze the oxi-
dation ofNADH by simultaneously reducing molecular 0 2 to 
either hydrogen peroxide, H20 2 , in a two-electron reduction 
(reaction 2), or directly to water in a four-electron reduction 
(reaction 3 ). 
(2) 
2NADH+02+2H.~2NAD•+2H20 (3) 
NADH oxidases contain a second cofactor, presumably 
covalently bound FAD, as evidenced by the consensus 
sequence GXT(H/S)AG near the N-terminus, and are wide-
spread among different, evolutionary distinct organisms, 
such as humans, vertebrates, plants, Drosophila and different 
US 8,530,213 B2 
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SEQ ID NO: 2. The purified nucleic acid sequence encoding 
an enzyme exhibiting oxidase activity has substantial homol-
ogy to SEQ ID NO 2. As used herein, the term "substantial 
homology" of a nucleic acid sequence means that a nucleic 
acid sequence includes a sequence that has at least 51 %, 52%, 
53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 
63%, 64%, 65%, 66%, 67%, 68%, or 69%, 70%, 71 %, 72%, 
73%, 74%, 75%, 76%, 77%, 78%, or79%, preferably at least 
80%, 81 %, 82%, 83%, 84%, 85%, 86%, 87%, 88%, or 89%, 
strains of bacteria. Bacteria harbor both H2 0 2 -forming and 
H2 0-forming NADH-oxidases. Owing to the deactivation of 
almost all proteins upon the exposure to H20 2 , the H20-
forming enzymes are superior as biocatalysts. Addition of 
catalase could potentially destroy the H2 0 2 formed, however, 
catalase itself features a very high KM"value of 1.1 M, so that 
the enzyme is not particularly active at low H2 0 2 concentra-
tions. Thermophilic bacteria usually only feature peroxide-
producing NADH oxidases, which, despite their superior sta-
bility, render them unfavorable for catalytic purposes. Water-
producing NADH-oxidases can be found in various 
organisms, such as Streptococcus, Enterococcus, Lactobacil-
lus, Mycobacterium, Methanococcus, or Leuconostoc. These 
organisms can contain both water- as well as peroxide-pro-
ducing enzymes. 
10 
more preferably at least 90%, 91 %, 92%, 93%, or 94%, and 
most preferably at least 95%, 96%, 97%, 98%, or 99% 
sequence identity, as compared to a reference sequence (e.g., 
SEQ ID NO: 2). 
15 As used herein, the term "NADH oxidase, which is derived 
from L. plantarum" is understood to include derivatives of a 
NADH oxidase isolated fromL. plant arum that are capable of 
oxidizing NADH, NADPH, or both NADH and NADPH. 
NADH oxidases derived from L. plantarum include recom-
binant nucleic acid sequences derived from the bacterial oxi-
dases of L. plantarum, recombinant proteins and peptides 
expressed by those sequences in heterologous hosts, and any 
nucleic acid or amino acid variants, mutants, or portions 
thereof (e.g., catalytically active portions) of bacterial oxi-
dases fromL. plant arum that are capable of oxidizing NADH, 
NADPH, or both NADH and NADPH. Thus, NADH oxi-
dases, which are derived from L. plantarum, can include 
proteins and recombinant constructs having altered 
sequences obtained by mutational methods. Embodiments of 
mutations of the sequences and resulting proteins disclosed 
herein also include, but are not limited to, substitutions, inser-
tions, deletions, additions, reversions, changes due to recom-
bination, and other mutations known to those skilled in the 
art. 
In one embodiment of the present invention, an NADH 
oxidase that is derived from L. plant arum can comprise SEQ 
ID NO: 1, wherein SEQ ID NO: 1 comprises at least one 
amino acid mutation that facilitates enzymatic activity 
towards NADPH. In another embodiment, an NADH oxidase 
The various embodiments of the present invention provide 
novel bacterial NADH oxidases. More specifically, the vari-
ous embodiment of the present invention provide an NADH 
oxidase obtained from Lactobacillus plantarum, and deriva-
tives thereof that demonstrate enzymatic activity for NADH, 20 
NADPH, or for both NADH and NADPH. The compositions 
comprising an NADH oxidase obtained fromL. plantarum or 
derivatives thereof include: isolated enzymes; recombinantly 
produced enzymes and derivatives thereof, as well as cata-
lytically active portions thereof; nucleic acids encoding an 25 
NADH oxidase obtained from L. plantarum, derivatives 
thereof, and portions thereof; vectors and plasmids compris-
ing an NADH oxidase obtained from L. plantarum, deriva-
tives thereof, and portions thereof; cells (i.e., prokaryotic or 
eukaryotic) comprising enzymes or nucleic acids encoding an 30 
NADH oxidase obtained from L. plantarum, derivatives 
thereof, and portions thereof. Compositions also include 
products made in enzymatic reactions in which an NADH 
oxidase obtained or derived from L. plantarum regenerates 
nicotinamide-based cofactors in the production of enanti- 35 
omer-enriched organic compounds. The methods of the 
present invention include isolation of NADH oxidase 
obtained from L. plant arum, derivatives thereof, and portions 
thereof, and methods for enzymatic reactions comprising 
NADH oxidase obtained from L. plantarum. 
As used herein, the term "NADH oxidase, which is 
obtained from L. plantarum" is understood to include the 
NADH oxidases isolated from L. plantarum, which are 
capable of oxidizing (sometimes referred to as "regenerat-
ing") NADH. An example of such an isolated NADH oxidase 45 
obtained from L. plantarum is illustrated by SEQ ID NO: 1. 
The term "NADH oxidase, which is obtained from L. plan-
tarum" also encompasses an amino acid sequence that 
encodes an enzyme exhibiting oxidase activity for NADH 
that has substantial homology to SEQ ID NO 1. As used 50 
herein, the term "substantial homology" of an amino acid 
sequence means that an amino acid sequence includes a 
sequence that has at least 51 %, 52%, 53%, 54%, 55%, 56%, 
57%, 58%, 59%, 60%, 61 %, 62%, 63%, 64%, 65%, 66%, 
67%, 68%, or 69%, 70%, 71 %, 72%, 73%, 74%, 75%, 76%, 55 
77%, 78%, or 79%, preferably at least 80%, 81 %, 82%, 83%, 
84%, 85%, 86%, 87%, 88%, or 89%, more preferably at least 
90%, 91 %, 92%, 93%, or 94%, and most preferably at least 
95%, 96%, 97%, 98%, or 99% sequence identity, as com-
pared to a reference sequence (e.g., SEQ ID NO: 1 ), provided 60 
that the enzymatic activity is retained or the purpose of the 
sequence is retained, e.g. coding for a protein having a spe-
cific enzymatic activity or a protein fragment having a par-
ticular binding capability or immunogenic capability. 
40 that is derived from L. plant arum can comprise SEQ ID NO: 
1, wherein SEQ ID NO: 1 comprises more than one amino 
acid mutation that facilitates enzymatic activity towards 
NADPH. One or more mutations to the amino acid sequence 
An NADH oxidase obtained from L. plantarum can be 65 
encoded by a nucleic acid sequence that encodes an enzyme 
with oxidase activity for NADH, such as that described in 
for an NADH oxidase that is derived from L. plantarum can 
confer enzyme activity to only NAD H, to only NAD PH, or to 
both NADH and NADPH. 
In one embodiment, an NADH oxidase that is derived from 
L. plantarum may include amino acid mutations to accom-
modate the negative charge associated with the phosphate 
moiety of NADPH so as to confer enzymatic activity for 
NADPH. Basic amino acids, such as arginine, lysine, and 
histidine, are preferred residues for substitution at amino acid 
residue 178, which is a glycine in the native enzyme, and 
amino acid residue 179, which is a leucine in the native 
enzyme. Consequently, amino acid residues 178 and 179 may 
be mutated to any one basic amino acid and various combi-
nations therebetween. Examples of such NADH oxidase 
derivatives include G 178K (SEQ ID NO: 3 ), G 178R (SEQ ID 
NO: 4), L179K (SEQ ID NO: 6), L179R (SEQ ID NO: 8), 
L1 79H (SEQ ID NO: 9), G 178K/Ll 79K (SEQ ID NO: 11 ), 
G178R/L179K (SEQ ID NO: 12), G178K/L179R (SEQ ID 
NO: 14), G178K/L179H (SEQ ID NO: 15), G178R/L179R 
(SEQ ID NO: 16), and G 178R/Ll 79H (SEQ ID NO: 17). 
These NADH oxidase derivatives are encoded by nucleic 
acids including G 178K/R (SEQ ID NO: 5), L1 79K (SEQ ID 
NO: 7), L179R/H (SEQ ID NO: 10), Gl 78K/R/Ll 79K (SEQ 
ID NO: 13), and G178K/R/Ll 79R/H (SEQ ID NO: 18). 
US 8,530,213 B2 
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The present invention also comprises nucleic acids that 
hybridize under stringent conditions with the single-stranded 
nucleic acids or their complementary single stranded nucleic 
acids of the present invention. Stringent conditions are well 
known to those skilled in the art; see Sambrook et al., (Mo-
lecular Cloning, A Laboratory Manual, Cold Spring Harbor 
Laboratory Press (1989), 1.101-1.104). Stringent conditions 
are established by conditions such as salt concentrations, 
temperature and amount of time for washing of the hybridized 
nucleic acids. For example, conditions include washing of 
hybridized nucleic acids in 0.1 % S DS and 1.0x to 0.2xSSC, 
at temperatures from 50° C. to 68° C., for times of0.5 to 1.0 
hours. 
The nucleic acids of the present invention can be incorpo-
rated into a vector. The term "vector" as used herein can refer 
to a cloning vector or an expression vector. A cloning vector 
refers to a plasmid, phage DNA, a cosmid, or other DNA 
molecule that is able to replicate autonomously in a host cell. 
A cloning vector is characterized by one or a number of 
restriction endonuclease recognition sites at which such DNA 
sequences may be cut in a determinable fashion without loss 
of an essential biological function of the vector, and into 
which a DNA fragment (e.g., SEQ ID NO: 2) may be spliced 
in order to bring about its replication and cloning. The cloning 
vector may further contain a marker suitable for use in the 
identification of cells transformed with the cloning vector 
(e.g., an antibiotic resistance marker). 
An expression vector is similar to a cloning vector but is 
capable of expressing a gene which has been cloned into it, 
after transformation into a host. The cloned gene is usually 
placed under the control of (i.e., operably linked to) a variety 
of elements for controlling expression of the gene, including 
promoter sequences, transcription initiation sequences, 
enhancer sequences, selectable elements, and reporter genes. 
Examples of suitable expression vectors include, but are not 
limited to, plasmids, phagemids, cosmids, artificial chromo-
somes, such as a yeast artificial chromosome (YAC), a bac-
terial artificial chromosome (BAC), or a Pl-derived artificial 
chromosome (PAC), and bacteriophages, such as lambda 
phage or M13 phage. 
The present invention comprises compositions comprising 
NADH oxidases obtained or derived from derived from L. 
plantarum and methods of making and using such oxidases, 
wherein the oxidases regenerate NAD+, NADP+, or NAD+ 
and NADP+. The ability of an oxidase to oxidize one or both 
of these cofactors renders it an extremely useful catalyst for 
coupled enzymatically-catalyzed oxidations. Thus, the 
present invention comprises bacterial oxidases that regener-
ate both NADP+ and NAD+. The present invention also com-
prises novel NADH oxidases that reduce oxygen directly to 
water, which also makes such enzymes useful in coupled 
enzymatic reactions. 
The NADH oxidases of the present invention participate in 
enzymatic reactions where there is a conversion of a substrate 
into a product. In a particularly preferred embodiment of the 
present invention, the product comprises an enantiomer-en-
riched organic compound. Consequently, the substrate can 
include a racemic mixture, such as an alcohol to a ketone, and 
upon enzymatic reaction will result in a highly enantiomer-
enriched unreacted optical antipode of the original molecule, 
such as an alcohol. Dehydrogenases are capable of very spe-
cific enantiomeric selection and are used to prepare enantio-
merically pure alcohols, hydroxy acids and amino acids as 
well as the corresponding ketones and keto acids. The dehy-
drogenase reaction requires the regeneration of the NADH or 
NADPH for cofactor activity, and thus, the NADH oxidases 
of the present invention have utility in coupled reactions with 
8 
dehydrogenases including, but not limited to, alcohol dehy-
drogenase, lactate dehydrogenase and amino acid dehydro-
genase. Products from such reactions include the resolution 
of racemic mixtures, such resolution dependent on the selec-
tivity of the dehydrogenase used, and resulting in the unre-
acted racemate from the original racemic mixture, and the 
product of the enzyme reaction. For example, from a racemic 
mixture of an R/S-alcohol, in a reaction with an S-alcohol 
dehydrogenase, the resulting products are the unreacted 
10 enantiomer, the R-alcohol, and the resulting product, e.g., a 
ketone. 
The NADH oxidases of the present invention are involved 
in synthesis methods comprising enzyme reactions where the 
substrates have one or more chiral centers. An embodiment of 
15 the present invention comprises a method of producing an 
enantiomer-enriched organic compound, comprising: react-
ing a substrate with a first enzyme selective for producing an 
enantiomer, wherein the first enzyme requires an oxidized 
nicotinamide-based cofactor for catalytic activity; producing 
20 the enantiomer and a reduced nicotinamide-based cofactor; 
and oxidizing the reducednicotinamide-based cofactor with a 
second enzyme selective for a nicotinamide-based cofactor. 
In such methods, the second enzyme selective for a nicotina-
mide-based cofactor comprises a NADH oxidase obtained or 
25 derived from L. plantarum. The oxidized nicotinamide-based 
cofactors can include NAD+, NADP+, or both NAD+ and 
NADP+. Embodiments of the present invention comprise 
isolated bacterial oxidases derived from L. plantarum that use 
NAD Hand NAD PH as a cofactor. In a preferred embodiment, 
30 isolated bacterial oxidases derived fromL. plantarum that use 
NADH and NADPH as a cofactor include SEQ ID NO: 8 or 
SEQ ID NO: 16. 
The compositions of the present invention also comprise 
combinations of all or a portion of one or more of SEQ ID NO: 
35 2, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 10, SEQ ID 
NO: 13, and SEQ ID NO: 18 with other nucleic acid 
sequences to encode chimera proteins, or the nucleic acids of 
NADH oxidases combined with proteins or attached to solid 
supports such as beads. Such chimera proteins or other com-
40 binations may or may not retain the enzyme activity ofNAD H 
oxidases. For example, a nucleic acid construct that codes for 
a chimera protein is constructed from SEQ. ID NO: 2 and 
sequences for an antibody protein or binding fragment 
thereof. Such a chimera can be used in antibody labeling 
45 experiments. 
The present invention also comprises compositions com-
prising the NADH oxidases disclosed herein that include 
immobilization of the enzymes on heterogeneous substrates. 
For example, the enzymes may be immobilized or attached to 
50 other proteins, through methods such as chemical linking of 
the proteins, attached to inert substrates such as microtiter 
plates, chromatography materials, balls, beads or other sub-
stances. The invention contemplates the use of such immo bi-
lized enzymes in methods of synthesis, measurement, analy-
55 sis or other methods wherein enzymes are used. These 
methods for immobilizing and using such immobilized 
enzymes are known to those skilled in the art. 
The compositions of the present invention also comprise 
antibodies and other specific binding partners, such as sub-
60 strates, of NADH oxidases, and immunogenic epitopes 
thereof. Such antibodies may be polyclonal or monoclonal, 
and include fragments such as Fab, FC, heavy chains, light 
chains, constant, variable, or hypervariable fragments or 
regions, and any type of antibody include but are not limited 
65 to IgM, IgG, IgA, IgD, and IgE. 
The compositions of the present invention also contem-
plate the inclusion of any cofactors, metals or other com-
US 8,530,213 B2 
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pounds or molecules necessary for activity or stability of the 
NADH oxidases of the present invention. However, it should 
be noted that the NADH oxidases of the present invention 
demonstrate stability in the absence of an exogenous reduc-
ing agent, such as dithiothreitol (DTT) or ~-mercaptoethanol. 5 
carried out by genetic engineering processes as described in, 
for example, Sambrook supra, Balbas P & Bolivar F. 1990; 
Design and construction of expression plasmid vectors in E. 
coli, Methods Enzymology 185, 14-37; Vectors: A Survey of 
Molecular Cloning Vectors and Their Uses. R. L. Rodriguez 
& D. T. Denhardt, Eds: 205-225). With regard to the general The present invention also comprises host cells comprising 
the nucleic acids disclosed herein, particularly SEQ ID NO: 
2, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 10, SEQ ID 
NO: 13, and SEQ ID NO: 18. Examples of such host cells 
include, but are not limited to, prokaryotes or eukaryotes, 10 
such as Pseudomonas, Streptomyces, Arthrobacter, Bacillus, 
Staphylococcus, Enterococcus, especially Escherichia coli, 
Candida, Hansenula, Pichia and various eukaryotic cells 
using for example viral-based expression systems. The host 
cells in which the nucleic acids are cloned are useful for 15 
procedure (PCR and fusion PCR, inverse PCR, cloning, 
expression etc.), reference may be made to the following 
literature and the references cited therein: Riley J, Butler R, 
Finniear R, Jenner D, Powell S, Anand R, Smith J C, 
MarkhamA F (1990). A novel, rapid method for the isolation 
of terminal sequences from yeast artificial chromosome 
(YAC) clones. Nucl Acids Res. 18, 8186; Triglia T, Peterson 
MG, Kemp DJ (1988). A procedure for in vitro amplification 
of DNA segments that lie outside the boundaries of known 
sequences. Nucleic Acids Res. 16, 8186; Sambrook J, Fritsch propagation and production of a sufficient amount of the 
recombinant enzyme or enzymes. The methods for cloning, 
propagating and producing recombinant proteins in cellular 
systems are well known in the art. 
The nucleic acids disclosed herein that code forthe NADH 
oxidases as described herein, are preferably suitable for the 
production of whole-cell catalysts. The invention provides a 
whole-cell catalyst containing a cloned gene for a first 
enzyme selective for producing an enantiomer (e.g., a dehy-
drogenase) and a cloned gene for a NADH oxidase, as dis-
closed herein. The whole-cell catalyst according to one 
embodiment of the invention can comprise a NAD H oxidase, 
preferably a bacterial oxidase obtained or derived from L. 
plantarum that can regenerate NAD+, NADP+, or both 
NAD+ and NADP+. More preferably, the NADH oxidase is 
one or more of the NADH oxidases disclosed herein and 
encoded for by SEQ ID NO: 2, SEQ ID NO: 5, SEQ ID NO: 
7, SEQ ID NO: 10, SEQ ID NO: 13, and SEQ ID NO: 18. The 
production of such an organism is known to the person skilled 
in the art as disclosed in PCT/EP00/08473 and PCT/USOO/ 
08159, which are hereby incorporated by reference. 
The advantage of such an organism is the simultaneous 
expression of at least two different enzymes, and as a result 
the whole cell catalyst recombinant organism is only used for 
the enzymatic reaction. In order to match the expression of the 
enzymes with respect to their reaction rates, the coding 
nucleic acids may be cloned into various plasmids having 
different copy numbers and/or promoters of different 
strengths. In one embodiment, the enzymes are encoded on 
plasmids with similar copy numbers in a host cell and/or 
under the control of promoters of similar strength. With 
enzyme systems matched in this way there is advantageously 
no accumulation of a possible inhibiting intermediate com-
pound(s ), and the reaction under consideration may proceed 
at an optimal overall rate. 
Methods of the present invention comprise methods for 
growing and isolating bacterial NADH oxidases, particularly 
bacterial oxidases obtained or derived from L. plantarum 
capable of regenerating NAD+, NADP+, or both NAD+ and 
NADP+. One embodiment comprises growing host organ-
isms, such as Lactobacillus plantarum, and isolating the 
NAD H oxidases by methods known to those skilled in the art, 
such as ammonium or acid precipitation, chromatography 
methods, and other protein purification techniques. 
The nucleic acids according to the invention can be used for 
the production of recombinant NADH oxidases, which is 
include NADH oxidases obtained or derived from L. plan-
tarum. Recombinant techniques known in the art can be used 
to produce the enzymes described herein in an amount suffi-
cient for an industrial process from host cells carrying the 
nucleic acids encoding the enzyme of interest. The produc-
tion of the recombinant enzymes according to the invention is 
E F, Maniatis T (1989). Molecular Cloning. Cold Spring 
Harbour Laboratory Press; Vectors: A Survey of Molecular 
Cloning Vectors and Their Uses. R. L. Rodriguez & D. T. 
20 Denhardt, II. 
The bacterial oxidase enzymes described herein may be 
used in the free form as homogeneously purified compounds, 
or as enzymes produced by recombinant technology. Further-
more the enzymes may also be employed as a constituent of 
25 an intact host organism or in conjunction with the macerated 
cell mass of the host organism purified to an arbitrarily high 
degree. It is also possible to use the enzymes in immobilized 
form (Bhavender P. Sharma, Lorraine F. Bailey and Ralph A. 
Messing, "Immobilisierte Biomaterialien-Techniken and 
30 Anwendungen", Angew. Chem. 1982, 94, 836-852). The 
immobilization is preferably carried out by lyophilisation 
(Dordick et al. J. Am. Chem. Soc. 194, 116, 5009-5010; 
Okahata et al. Tetrahedron Lett. 1997, 38, 1971-1974; Adler-
creutz et al. Biocatalysis 1992, 6, 291-305). It is most par-
35 ticularly preferred to carry out the lyophilisation in the pres-
ence of surfactants such as aerosol OT, polyvinylpyrrolidone, 
polyethylene glycol (PEG) or Brij 52 (diethyleneglycol-
monocetyl ether) (Goto et al. Biotechnol. Techniques 1997, 
11, 375-378). The use as CLECs is also possible (St Clair et 
40 al. Angew Chem Int Ed Engl 2000 January, 39(2), 380-383). 
The present invention also comprises using NADH oxi-
dases obtained or derived from L. plantarum having NAD+, 
NADP+, or both NAD+ and NADP+ regeneration activity 
(e.g., G178K (SEQ ID NO: 3), G178R (SEQ ID NO: 4), 
45 L1 79K (SEQ ID NO: 6), L1 79R (SEQ ID NO: 8), L1 79H 
(SEQ ID NO: 9), G 178K/Ll 79K (SEQ ID NO: 11 ), G 178R/ 
L179K (SEQ ID NO: 12), Gl 78K/Ll 79R (SEQ ID NO: 14), 
G178K/L179H (SEQ ID NO: 15), G178R/L179R (SEQ ID 
NO: 16), and G 178R/Ll 79H (SEQ ID NO: 17). These NADH 
50 oxidase derivatives are encoded by nucleic acids including 
G178K/R (SEQ ID NO: 5), L179K (SEQ ID NO: 7), 
L179R/H (SEQ ID NO: 10), G 178K/R/Ll 79K (SEQ ID NO: 
13), and G178K/R/L179R/H (SEQ ID NO: 18)) and any 
mutations thereof, for the production of chiral enantiomer-
55 enriched organic compounds such as, for example, alcohols, 
amino acids, or nucleosides, in coupled enzymatic reactions. 
Such compounds are useful in pharmaceutical preparations, 
in agricultural uses, for food, and crop protection industries as 
well as building blocks for novel compounds not accessible 
60 through fermentation and for asymmetric synthesis tem-
plates. For example, compounds are produced that are effec-
tive in treatment of humans and other animals for hyperten-
sion, diabetes, cardiovascular disease, cancer, infectious 
disease, and conditions involving the brain, eyes, heart, lungs, 
65 liver, immune system, urinary organs, reproductive organs, 
integumentary system, nervous system and other conditions 
where pharmaceutical agents are effective. 
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All patents, patent applications, and references included 
herein are specifically incorporated by reference in their 
entireties. 
12 
Materials and Methods 
Cloning and Site-Directed Mutagenesis. 
It should be understood, of course, that the foregoing 
relates only to exemplary embodiments of the present inven- 5 
tion and that numerous modifications or alterations may be 
made therein without departing from the spirit and the scope 
of the invention as set forth in this disclosure. Therefore, 
while embodiments of this invention have been described in 
The gene encoding NADH oxidase from Lactobacillus 
plantarum V was cloned out from the original plasmid 
through PCR using the following primers: forward primer 
(SEQ ID NO: 19) (5'-TGCATGCATGCCATGGTTAT-
GAAAGTTATTGTAATTGGTTGTACCCA-3') and reverse 
primer (SEQ ID NO: 20) (5'-CCGCCGCCGCCG 
CTCGAGTTATTCAGTGACAGCTTCGGCC-3'). The PCR 
product was then gel purified with a Qiagen gel extraction kit 
and cloned into a pET-28a vector (Novagen, Inc.) using detail with particular reference to exemplary embodiments, 
10 
those skilled in the art will understand that variations and 
restriction sites Neal and Xhol. The plasmid was then trans-
formed into BL21(DE3)pLysS for expression. modifications can be effected within the scope of the inven-
tion as defined in the appended claims. Accordingly, the scope 
of the various embodiments of the present invention should 
not be limited to the above discussed embodiments, and 
should only be defined by the following claims and all equiva-
lents. 
The present invention is further illustrated by way of the 
examples contained herein, which are provided for clarity of 
understanding. The exemplary embodiments should not to be 
construed in any way as imposing limitations upon the scope 
thereof. On the contrary, it is to be clearly understood that 
resort may be had to various other embodiments, modifica-
tions, and equivalents thereof which, after reading the 
description herein, may suggest themselves to those skilled in 
the art without departing from the spirit of the present inven-
tion or the scope of the appended claims. 
EXAMPLES 
Example 1 
NADH Oxidase Isolated from Lactobacillus 
plantarum 
Single and double mutations were performed on residues 
15 G 178 and L179 into K, Rand K, R, H respectively, through 
overlap and quikchange PCR using the following forward 
primers and their complementary reverse primers; G 178K/R 
(SEQ ID NO: 21) (5'-GCAAGGTAAGGAAGTCACAC-
TAATTGATARRTTACCACGGATTTTAAATAAATACT 
20 TAGACAA-3'), L179H/R (SEQ ID NO: 22) (5'-AGGTAAG-
GAAGTCACACTAATTGATGGT 
CRYCCACGGATTTTAAATAAATACTTAG ACAAAG-3'), 
L179K (SEQ ID NO: 23) (5'-AGGTAAGGAAGTCACAC-
TAATTGATGGT 
25 AAACCACGGATTTTAAATAAATACTTAG ACAAA-3'), 
G 178K/R/Ll 79R/H (SEQ ID NO: 24) (5'-GCAAGGTAAG-
GAAGTCACACTAATTGAT 
ARRCRYCCACGGATTTTAAATAAATACT TAGA-




CAAA-3'). Degenerate codons for K/R and H/R were used as 
ARR and CRY respectively. 
Overexpression. 
Growth and overexpression was carried out in MagicMe-
dia ™ E. coli Expression Medium (Invitrogen) with a final 
concentration of 30 µg. mL- 1 of kanamycin and chlo-
romphenicol. A dual temperature protocol was used for 
growth, starting out at 30° C. for 6 hours, and then continued 
40 at room temperature for an additional 22 hours. Cultures were 
harvested by centrifugation in a Beckman centrifuge with a 
JS-5.2 rotor at 4000 rpm for 20 minutes in 50 mL conical 
tubes. The resulting cell pellet was either frozen, and stored at 
Among the different systems that can be chosen for cofac-
tor regeneration, the use ofNADPH oxidases standout with a 
number of advantages. NADPH oxidases utilize NADPH and 
oxygen as co-substrates, both which would not needed to be 
added externally for a regeneration system. (FIG. 1). This 
would prevent complication of the system by introducing 
additional substrates. The reaction would either produce 
water or hydrogen peroxide as final products, and the latter 45 
can be easily eliminated through the use of catalases. 
-80° C. or purified directly. 
Enzyme Assay and Protein Determination. 
Standard assays were performed at 25° C. in 100 mM TEA 
buffer (pH 7 .5) with 5 mM DTT in cuvettes with either a 1 cm 
or 1 mm path length, depending on the concentration of 
substrate. Initial activity was measured by following the 
Overoxidation of the catalytically active cysteine residue 
has been shown to be a limitation in production for previous 
NADPH oxidases. All of the previously discovered NADPH 
oxidases have shown to have a cysteine residue that is cata-
lytically active. This thiol is oxidized to sulfenic acid and 
reduced back to the thiol as a part of the NADPH reduction 
mechanism. Studies have also shown that during this redox 
cycle the cysteine can also be overoxidized, producing a 
sulfinic or sulfonic acid, killing the enzymatic activity. This 
has been overcome to some extent by using reducing agents 
such as dithiothreitol (DTT) and ~-mercaptoethanol. These 
reducing agents have shown to prevent overoxidation, thus 
elongating the catalytically active enzyme lifetime. 
As demonstrated in this Example, NADH oxidase from 
Lactobacillus plantarum V is different in that it has a higher 
productivity indicated by its total turnover number (TTN) and 
50 absorbance change using a Beckman Coulter DU 800 UV Nis 
spectrophotometer at 340 nm. Activity of the enzyme was 
calculated using an extinction coefficient ofNAD(P)H, E, as 
6.22 mM- 1 cm- 1 . Unless otherwise noted, a substrate con-
centration of0.2 mM NADPH was used for assays. 1 unit (U) 
55 of activity is defined as 1 mo! min- 1 . 
60 
The protein concentration was determined by a Bradford 
assay. BSA was used as standards, and the absorbance was 
measured on a biophotometer. SDS-page analysis was per-
formed to determine to purity. 
Purification. 
is more stable against overoxidation as compared to its pre-
decessors. While the native enzyme only showed activity on 65 
NADH, mutations in the substrate binding pocket were intro-
duced to change its specificity and to accommodate NADPH. 
Purification ofNOX5 was carried out at 4° C. or on ice to 
prevent denaturation of the enzyme. Cell pellets were resus-
pended in 15 mL of 10 mM Tris-HCI buffer (pH 7.5) with 5 
mM DTT (Buffer A) and sonicated at 14 watts for30 seconds 
nine times in an ice water bath. Sonicated cells were centri-
fuged at 15000 rpm in a Beckman 12-21 with a JA-21 rotor for 
30 minutes. The clarified cell lysate was transferred to a 
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dialysis membrane and dialyzed against 250 mL of Buffer A 
with 50% ammonium sulfate for 2 hours. The dialysis mem-
brane was then transferred to fresh buffer and further dialyzed 
for 2 hours. The solution was then centrifuged at 15000 rpm 
for 30 minutes. The resulting supernatant was filtered through 5 
a 0.8 µM filter and 0.2 µM filter in series. The filtrate was 
loaded onto a HIPREP™ 16/10 Butyl colunm on an AK TA. A 
reverse gradient separation was performed starting from 
Buffer A with 30% ammonium sulfate to 15%. The fractions 
with the highest activity were collected and dialyzed against 10 
a Buffer A for 2 hours. After exchanging the fresh buffer, the 
sample was dialyzed for an additional 2 hours. The sample 
was loaded on a HIPREP™ 16/10 DEAE anionic exchange 
colunm on the AK TA. Separation was achieved with Buffer A 
containing NaCl, a gradient of 150 mM to 250 mM. The 15 
resulting fractions were assayed, and the fractions with high-
est activity were collected as pure protein. The purified pro-
tein was either stored in 4 ° C. or in -20° C. with 25% glycerol. 
pH Activity. 
Enzyme pH activity profiles were obtained at 25° C. using 20 
100 mM buffers with the following salts: sodium citrate from 
pH 4.0 to pH 6.5; sodium phosphate from pH 6.0 to pH 8.0; 
TEA from pH 7.0to pH 8.0; Tris-HCl from pH 7.0to pH 9.0; 
glycine from pH 9.0 to pH 10.0. 
14 
Purification ofNOX5 resulted in a yield of 14% of the total 
units and a 12.7 fold increase of specific activity. Purified 
NOX 5 shows a strong band at 49 kDa in SDS-page analysis. 
Table 1 is a table of purification. "Lysate" refers to clarified 
lysate; "AS50 dia." refers to the supernatant from centrifuged 
sample dialyzed against 50% ammonium sulfate; "Butyl dia." 
refers to the fractions collected from HIPREP™ 16/10 Butyl 
column dialyzed against 100 mM TEA pH 7.5 and 5 mM 
DTT; and "DEAE" refers to fractions collected from 
HIPREP™ 16/10 DEAE colunm. 
TABLE 1 
Volume Units Protein Sp. ac. Purification Yield 
(ml) (U) (mg) (Umg- 1) Fold (%) 
Lysate 20 1843.5 139.3 13.24 1.0 100 
AS50 7 930.0 88.5 10.51 0.8 50 
dia. 
Butyl 37.5 379.3 4.7 80.72 6.1 21 
dia. 
DEAE 20 261.9 1.6 167.5 12.7 14 
Enzyme Activity and Stability. 
NADPH oxidases will mostly be used in cofactor regen-
Temperature Activity. 
Temperature dependent activity was studied by incubating 
the enzyme at different temperatures. After one minute of 
incubation, the standard assay was carried out. A temperature 
range of 10 to 55° C. was chosen for this study. 
Temperature Stability. 
25 eration, as water and hydrogen peroxide are not of great 
interest for final products. As the true value of these enzymes 
are shown when they are coupled with other enzymes, the 
study of reaction conditions, especially in terms of pH and 
temperature, were necessary to maximize activity and stabil-
Temperature stability was studied by incubating the 
enzyme at various temperatures for 30 minutes. The enzyme 
solution was then cooled down and assayed at 25° C. This 
study covered a temperature range of 15° C. to 55° C. 
Kinetic Parameters. 
Depending on the enzyme, a substrate concentration range 
from 1.5 µM up to 984 µM was investigated to determine the 
kcat and KMofNADPH. This was conducted with an excess of 
oxygen present in the system. The reaction was initiated by 
mixing two separate 2x solutions of each the substrate and 
enzyme. The specific activity was measured, and the kinetic 
parameters were calculated from that data. 
30 ity. 
35 
NOX5 showed a rather broad pH activity range. Maximum 
activity was found at pH 7 .5, but the enzyme was fairly active 
from pH 5.5 to 8.0. (FIG. 2). This is a range that is common for 
many NADPH oxidases. The upper limit is also compatible 
with dehydrogenases that are active in alkaline conditions. 
Although it would be difficult to have a single corresponding 
maximum for both enzymes, a person of ordinary skill in the 
art could identify optimal conditions for a dehydrogenase and 
40 NOX5. 
Inhibition effects of NAD+ and H2 0 2 were measured by 
incubating the enzyme with possible inhibitors for 30 minutes 
before the assay. For NAD+, 0.2, 0.3, 0.4 and 0.6 mM were 45 
chosen and for H20 2 , 25, 50, 100 and 200 µM were investi-
gated. 
The temperature activity profile showed that maximum 
instantaneous activity was found at 40° C., and the activity 
quickly reached zero beyond that. (FIGS. 3 and 4). Using an 
Arrhenius model, the activation energy, Ea, was calculated as 
32.7 kJ mo1- 1 , and the deactivation energy, Ed, was calculated 
as -93.6 kl mo1- 1 . The temperature that exhibited half of the 
original activity, T 5030, was estimated to be 45° C. At 55° C., 
the enzyme was inactive. Enthalpy of deactivation, li.H, was 
calculated to be 4.98 kJ·mo1- 1 . 
Amplex Red Assay. 
An Amp lex Red Hydrogen Peroxide/Peroxidase Assay Kit 
(Invitrogen) was used to determine the amount of hydrogen 50 
peroxide (H20 2 ) produced during turnover. Various amounts 
Kinetic Parameters. 
The data was fitted with four different models: non-linear 
Michaelis-Menten, Lineweaver-Burk, Eadie-Hofstee and 
Hanes. Through non-linear fitting, kcat and KM of the wild 
type were measured to be 211.6 s- 1 and 50.2 µM, respectively 
of substrates were reacted and assayed to detect the presence 
of H20 2 . The reactions were carried out in the provided 50 
mM sodium phosphate buffer (pH 7.4). Standards for the 
calibration curve were made with the same reaction buffer. 
Total Turnover Number (TTN). 
Standard kinetic assays were performed with small 
amounts of enzyme. Assays were carried out for two to three 
hours until there was no more enzymatic conversion of the 
substrate. 
Results and Discussion 
NADH oxidase V from Lactobacillus plantarum (NOX5) 
consists of 1350 bp and has a predicted size of 49 kDa. 
Sequencing of the gene (SEQ ID NO. 1) showed a nucleotide 
mutation ofC to Tat position 45, but the resulting amino acid 
sequence (SEQ ID NO. 2) was the same as the predicted 
sequence. 
55 with an R2 of0.998. (FIG. 5). 
Possible product inhibitory effects were investigated by 
incubating the enzyme with different concentrations of 
NAD+. NAD+ exhibited a non-competitive inhibition pattern 
where the U max mg- 1 decreased as the inhibitor concentration 
60 increased while KM.app was consistent. Analysis of the differ-
ent concentrations showed that the KI ofNAD+ was 289 µM. 
(FIG. 6). 
To determine whether NOX5 is a water or hydrogen per-
oxide producing enzyme, an amplex red assay was per-
65 formed. The presence ofH2 0 2 can be confirmed by incubat-
ing the standard assay mixture with amplex red and 
peroxidase. Produced resorufin can be detected using a fluo-
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rescence spectroscopy analysis. NOX5 produced H20 2 at a 
2.63% ratio of NADH strongly suggesting that it is a water 
forming NADPH oxidase. 
Total Turnover Number (TTN). 
Total turnover number (TTN) is a measurement of catalyst 5 
productivity. For biocatalysts, TTN is defined as the total 
amount of product produced over the lifetime of an enzyme. 
Calculations ofTTN were performed by dividing the change 
ofNADPH concentration by the amount of enzyme that was 
used for each assay. In the standard assay conditions with the 10 
presence of DTT the TTN was found to be about 168,000, 
consistently, at 25° C. (data not shown). 
This experiment was repeated to see if the presence of 
reducing agents had any effect on the total turnover number. 15 
The stock solution of enzyme was dialyzed against 250 mL of 
10 mM Tris-HCl (pH 7.5) for two hours. The solution was 
then exchanged and dialyzed for an additional 2 hours. The 
TTN was then measured with the dialyzed enzyme with and 
without reducing agents. DTT and ~-mercaptoethanol 20 
(~-ME) were used at a concentration of 5 mM. The TTN for 
the sample with no reducing agents, DTT and ~-ME were 
128,000, 168,000 and 107,000, respectively. The presence of 
DTT had a positive effect, but it was not as dramatic com-
pared to the NADH oxidase from Lactobacillus sanfranci- 25 
scensis. ~-ME did not have a positive effect at all and actually 
decreased the TTN. 
To examine TTN limitation possibilities, three properties 
were investigated: i) thermal stability of enzyme at 25° C.; ii) 
presence of hydrogen peroxide (H20 2 ) and stability of 30 
enzyme against it; and iii) product (NAD+) inhibition in the 
system. 
Thermal stability at 25° C. was measured by incubating the 
enzyme for extended periods of time. The enzyme was then 
assayed to check the remaining activity (data not shown). The 35 
thermal stability at 25° C. was investigated in order to show 
the relevance of thermal degradation during turnover. 
Through this study, it can be concluded that the enzyme 
shows to be inactive before it is thermally deactivated. 
The effect ofH2 0 2 was studied with a concentration range 40 
up to 200 µM, which would be the total amount produced 
from a standard assay if the enzyme was a hydrogen peroxide 
producing NADPH oxidase. Even at high concentrations, 
there was no change found in the initial specific activity (data 
not shown), thus showing that the enzyme is indeed quite 45 
stable against H20 2 . 
The presence of NAD+ inhibition, and its pattern was 
known. However, even at high concentrations ofNAD+, there 
was a reasonable amount of activity. So, it would be difficult 
to conclude that NAD+ had inhibited the reaction completely. 50 
Example 2 
Mutation ofNADH Oxidase from Lactobacillus 
plantarum for NADPH Activity 55 
16 
Single mutations were done on residues G 178 and Ll 79 
into K, Rand K, R, H respectively, and double mutations were 
also investigated with different combinations of the single 
mutations. The mutation of G 178H was excluded due to the 
fact that the enzyme would then have two histidines next to 
each other, creating steric hindrance in the binding pocket. 
The resulting mutants were expressed on small scale and 
assayed at the cell lysate level. Table 2 provides the NOX5 
mutants and the activity of the mutants at the cell lysate level. 
Among the mutants, Ll 79R retained the highest amount of 
NADH activity, and G 178R/Ll 79R had the highest activity 
for NADPH. Although not wishing to be bound by any par-
ticular theory, it is believed that a positive charge is intro-
duced through the mutation at L179R, and the additional 
mutation at G 178R stabilizes the positioning, effectively 
decreasing the amount of free rotation of Ll 79R through 
hydrogen bonding. It seems reasonable for arginine to have 
the largest effect, as it has the most options for hydrogen 
bonding. The low activity ofLl 79H can be explained by the 
presence of an adjacent praline causing steric hindrance. 
TABLE2 
NADH activity NADPH activity 
Mutant (U/mg) (U/mg) 
Wild Type 10.0 0.00 
G178K 3.92 0.46 
G178R 1.51 0.23 
L179K 5.14 1.03 
L179R 7.32 1.76 
L179H 1.37 0.64 
G1 78K/Ll 79K 0.84 3.11 
G1 78K/Ll 79R 2.00 5.68 
G1 78K/Ll 79H 1.24 3.85 
Gl 78R/Ll 79K 0.94 3.56 
Gl 78R/Ll 79R 2.64 6.00 
Gl 78R/Ll 79H 0.64 0.52 
Study of mutants L179R and G 178R/Ll 79R. L179R and 
G 178R/Ll 79R were selected for further purification. Table 3 
provides kinetic parameters of wild-type (WT) and mutant 
NADPH oxidases. L179R was not as active as the wild-type 
having a kcat. NADHof 122.0 s- 1 . However, the KM. NADH was 
much lower at 6.56 µM, improving the kcalKM by more than 
4-fold. The mutant also showed NADPH activity but had a 
very high KM of 489 .6 µM. The double mutant G 178R/Ll 79R 
also had the same trend for NADH as Ll 79R but to a larger 
extent. The kcat NADH was 34.0 s- 1 and the KM NADH was 34.0 
µM, resulting i{i a kcalKMof 13.2 µM- 1s- 1 . It also showed a 
kcjKMforNADPHat 11.7 µM- 1 s- 1 , whereat, NADPHwas 
114.1 s- 1 and the KM NADPH was 9.76 µM. Overall, both 




kc at KM kca/KM kcat KM kca/KM 
enzyme (s-1) (µM) (µM-1. s-1) (s-1) (µM) (µM-1. s-1) 
60 WT 
Since the wild type NOX5 had activity exclusively towards 
NADH, and had little to no activity towards NADPH, muta-
tional options were investigated to introduce NADPH activ-
ity. Crystal structure comparisons ofNADPH oxidase from 
Lactobacillus sanfranciscensis and a homology model of 
NOX5 from Lactobacillus plantarum showed differences in 
where the 2'-phosphate would be located. The one from L. 
sanfranciscensis had a histidine, which would be able to 
accommodate the negative charge but NOX5 only had hydro- 65 
phobic residues in that area. Based on this knowledge, differ-
ent basic residues were chosen for mutation in that region. 








146.4 489.6 0.30 
114.1 9.76 11.7 
The TTN of the mutants were measured and the same trend, 
where the presence of reducing agents did not affect the 
enzyme to a great extent, was found. The double mutant 
US 8,530,213 B2 
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successfully exhibited NADPH activity, expanding the range 
of applications where this enzyme could be used. 
Example 3 
Higher Operational Stability of Lactobacillus 
plantarum NAD(P)H Oxidase (Higher Total 
Turnover Number) 
Comparison ofNADPH oxidases. Table 4 provides a com-
parison ofTTN with and without DTT, for NADH oxidases 


















TTN DTT TTN DTT 
128,000 168,000 
181,000 149,000 
108,000 128,000 105,000 118,000 
5,000 112,500 
38,740 78,480 
NOXS has shown a higher total turnover number with and 
even without any reducing agents. This is an indication of 
improved stability against overoxidation at the catalytically 
active cysteine residue. Since there are known effects of inhi-
bition ofDTT on certain rare sugar producing dehydrogena-
ses, such as mannitol dehydrogenase fromApium graveolens, 
it is preferable for an NADPH oxidase to be is stable without 
DTT. Also, improved stability without reducing agents would 
be a advantage in the pharmaceutical industry (or any other 
area that is related for the matter) where the presence of these 
reducing agents lack acceptability. 
A broad study ofNOX5 fromLactobacillus plantarum was 
conducted to study the possibility of an NADPH oxidase 
stable against overoxidation. In this study, pH and tempera-
ture characteristics were investigated to identify a common 
ground for enzyme coupled systems. Kinetic parameters 
were defined and the TTN was studied to discover the advan-
tages compared to previous NADPH oxidases. Through this 
study, the high stability of this enzyme was proven with and 
without the presence of reducing agents. 
As the wild-type enzyme demonstrates specificity for a 
NADH substrate, in order to be able to utilize NADPH, muta-
tions were made to change the specificity of the enzyme. By 
positioning different positively charged residues to interact 
and accommodate the 2'-phosphate of NADPH, it was pos-









SEQ ID NO, 2-NADH Oxidase Obtained from 

































35 SEQ ID NO, 3-NADH Oxidase Derived from 










45 SEQ ID NO, 4-NADH Oxidase Derived from 











broaden the range and usage of this NADPH oxidase, that has 55 SEQ ID NO, 5-NADH Oxidase Derived from 
higher stability against over oxidation than its predecessors. Lactobacillus plantarum, Gl 78K/R mutants 
SEQUENCE LISTING 








































SEQ ID NO, 6-NADH Oxidase Derived from 











SEQ ID NO, 7-NADH Oxidase Derived from 






























SEQ ID NO, 8-NADH Oxidase Derived from 














SEQ ID NO, 9-NADH Oxidase Derived from 











15 SEQ ID NO, 10-NADH Oxidase Derived from 































SEQ ID NO, 11-NADH Oxidase Derived from 











SEQ ID NO, 12-NADH Oxidase Derived from 










SEQ ID NO, 13-NADH Oxidase Derived from 


































SEQ ID NO, 14-NADH Oxidase Derived from 











SEQ ID NO, 15-NADH Oxidase Derived from 











SEQ ID NO, 16-NADH Oxidase Derived from 











SEQ ID NO, 17-NADH Oxidase Derived from 














SEQ ID NO, 18-NADH Oxidase Derived from 































SEQ ID NO, 19-Forward Cloning Primer for NADH 
Oxidase from Lactobacillus plantarum 
TGCATGCATGCCATGGTTATGAAAGTTATTGTAATTGGTTGTACCCA 
35 SEQ ID NO, 20-Reverse Cloning Primer for NADH 
Oxidase from Lactobacillus plantarum 
CCGCCGCCGCCGCTCGAGTTATTCAGTGACAGCTTCGGCC 
SEQ ID NO, 21-Forward Primer for NADH Oxidase 




SEQ ID NO, 22-Forward Primer for NADH Oxidase 
for Lactobacillus plantarum L179H/R mutants 
AGGTAAGGAAGTCACACTAATTGATGGTCRYCCACGGATTTTAAATA 
AATACTTAGACAAAG 
SEQ ID NO, 23-Forward Primer for NADH Oxidase 
for Lactobacillus plantarum L179K mutant 
AGGTAAGGAAGTCACACTAATTGATGGTAAACCACGGATTTTAAATA 
AATACTTAGACAAA 
50 SEQ ID NO, 24-Forward Primer for NADH Oxidase 




55 SEQ ID NO, 25-Forward Primer for NADH Oxidase 
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-continued 
1 5 10 15 
Asn Gln Ile Leu Ala Ser Asn Pro Asp Thr Glu Val Thr Ile Tyr Glu 
20 25 30 
Arg Asn Asp Asn Val Ser Phe Leu Ser Cys Gly Ile Ala Leu Tyr Leu 
35 40 45 
Gly Gly Gln Val Ala Asp Pro Gln Gly Leu Phe Tyr Ser Ser Pro Glu 
50 55 60 
Gln Leu Ala Lys Leu Gly Ala Thr Val His Met Gln His Asp Val Thr 
65 70 75 80 
Asp Val Asn Thr Asp Lys His Glu Ile Thr Val Thr Asp Leu Lys Thr 
85 90 95 
Gly Glu Ser Lys Thr Asp His Tyr Asp Lys Leu Val Val Thr Thr Gly 
100 105 110 
Ser Trp Pro Val Ile Pro Pro Ile Asp Gly Ile Asp Ser Pro Asn Val 
115 120 125 
Tyr Leu Cys Lys Asn Trp Thr His Ala Gln Asn Leu Trp Glu Ala Ala 
130 135 140 
Lys Pro Ala Lys Arg Val Ile Val Ile Gly Gly Gly Tyr Ile Gly Thr 
145 150 155 160 
Glu Leu Val Glu Ala Tyr Gln Lys Gln Gly Lys Glu Val Thr Leu Ile 
165 170 175 
Asp Gly Leu Pro Arg Ile Leu Asn Lys Tyr Leu Asp Lys Glu Phe Thr 
180 185 190 
Asp Arg Val Glu Gln Asp Phe Val Asp His Gly Ile Lys Met Ala Leu 
195 200 205 
Asn Gln Met Val Gln Gly Phe Ser Asp Asp Gly Lys Glu Val Thr Val 
210 215 220 
Lys Thr Asp Lys Gly Ser Tyr Thr Ala Asp Met Ala Ile Leu Cys Val 
225 230 235 240 
Gly Phe Arg Pro Asn Thr Gly Leu Leu Lys Gly Lys Val Asp Met Asn 
245 250 255 
Ala Asn Gly Ser Ile Lys Thr Asn Asp Tyr Met Gln Thr Ser Asp Pro 
260 265 270 
Asp Ile Tyr Gly Ala Gly Asp Ser Val Ala Val His Tyr Asn Pro Thr 
275 280 285 
Lys Lys Asp Ala Tyr Ile Pro Leu Ala Thr Asn Ala Val Arg Gln Gly 
290 295 300 
Thr Leu Val Gly Leu Asn Ile Phe Lys Pro Thr Arg Lys Tyr Met Gly 
305 310 315 320 
Thr Gln Ser Thr Ser Gly Leu Met Leu Phe Gly Gln Thr Ile Val Ser 
325 330 335 
Ser Gly Met Thr Leu Glu His Ala Gln Ala Glu Asn Val Pro Ala Ala 
340 345 350 
Ala Val Thr Phe Glu Asp Asn Tyr Arg Pro Glu Phe Met Pro Thr Thr 
355 360 365 
Lys Pro Val Leu Met Gln Leu Val Tyr Asn Pro Glu Thr Arg Glu Ile 
370 375 380 
Leu Gly Ala Gln Phe Met Ser Glu His Asp Val Ser Gln Ser Ala Asn 
385 390 395 400 
Val Ile Ser Val Met Ile Gln Asn His Asn Thr Ile Asp Asp Leu Gly 
405 410 415 
Phe Val Asp Met Phe Phe Gln Pro Ile Tyr Asp Arg Pro Phe Asn Tyr 
420 425 430 
28 
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29 
-continued 
Leu Asn Leu Leu Gly Gln Ala Ala Ile Ala His Ala Ala Glu Ala Val 
Thr Glu 
450 
435 440 445 
<210> SEQ ID NO 2 
<211> LENGTH, 1353 
<212> TYPE, DNA 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 2 
atgaaagtta ttgtaattgg ttgtacccat gccggcactg ctgctgttaa tcagatttta 
gcatcaaatc cagatactga agtgacgatt tatgaaagaa atgacaatgt ctcgttccta 
tcctgtggga tcgcacttta ccttggcggc caagttgctg atcctcaagg cctattttat 
tccagtcctg aacagttagc taagttaggc gcaactgttc atatgcaaca tgatgtgacg 
gatgtgaata ctgacaaaca tgaaattacg gttactgact taaagactgg tgaatctaag 
actgatcact atgacaagtt agttgtcact actggttcat ggcctgttat tccaccaatt 
gacggcatcg atagtcccaa tgtctactta tgcaagaact ggacgcacgc tcagaattta 
tgggaagcag ccaaaccagc taagcgggtc attgtgatcg gtggcggtta tatcggtact 
gaattagttg aagcttacca gaagcaaggt aaggaagtca cactaattga tggtttacca 
cggattttaa ataaatactt agacaaagaa ttcactgacc gggttgaaca agactttgtt 
gatcacggta tcaagatggc tttgaatcaa atggtgcaag gcttcagtga tgatggtaaa 
gaagttacgg tcaagactga caagggcagc tacacagccg acatggcgat tctttgtgtt 
ggcttccggc caaataccgg cttactcaag ggcaaggtcg atatgaacgc taatggctcg 
atcaagacca atgactacat gcaaacttct gatccagaca tttacggggc tggtgactcg 
gttgctgttc actataaccc aactaagaaa gatgcttata tcccattagc aacgaatgcg 
gttcgccaag gaaccttagt tggtttgaac atcttcaagc caacgcggaa gtacatgggg 
acacaatcaa cttctgggtt aatgttgttc ggccaaacca tcgtttcatc tgggatgacc 
ctagaacatg cacaggccga aaatgttccg gcagccgctg tcacttttga agacaactac 
cggccagaat ttatgccaac cactaagcct gttttaatgc aattggttta caatcctgaa 
actcgcgaaa tcctaggtgc acaattcatg agtgaacatg atgtttcgca atcagccaat 
gtgatttcag tgatgattca aaatcacaat accattgacg acttagggtt cgtagatatg 
ttcttccaac caatttacga ccggccattt aactatttga acttacttgg tcaagcagcg 
attgcccatg cggccgaagc tgtcactgaa taa 
<210> SEQ ID NO 3 
<211> LENGTH, 450 
<212> TYPE, PRT 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 3 
Met Lys Val Ile Val Ile Gly Cys Thr His Ala Gly Thr Ala Ala Val 
1 5 10 15 
Asn Gln Ile Leu Ala Ser Asn Pro Asp Thr Glu Val Thr Ile Tyr Glu 
20 25 30 
Arg Asn Asp Asn Val Ser Phe Leu Ser Cys Gly Ile Ala Leu Tyr Leu 
35 40 45 
Gly Gly Gln Val Ala Asp Pro Gln Gly Leu Phe Tyr Ser Ser Pro Glu 
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31 
-continued 
Gln Leu Ala Lys Leu Gly Ala Thr Val His Met Gln His Asp Val Thr 
65 70 75 80 
Asp Val Asn Thr Asp Lys His Glu Ile Thr Val Thr Asp Leu Lys Thr 
85 90 95 
Gly Glu Ser Lys Thr Asp His Tyr Asp Lys Leu Val Val Thr Thr Gly 
100 105 110 
Ser Trp Pro Val Ile Pro Pro Ile Asp Gly Ile Asp Ser Pro Asn Val 
115 120 125 
Tyr Leu Cys Lys Asn Trp Thr His Ala Gln Asn Leu Trp Glu Ala Ala 
130 135 140 
Lys Pro Ala Lys Arg Val Ile Val Ile Gly Gly Gly Tyr Ile Gly Thr 
145 150 155 160 
Glu Leu Val Glu Ala Tyr Gln Lys Gln Gly Lys Glu Val Thr Leu Ile 
165 170 175 
Asp Lys Leu Pro Arg Ile Leu Asn Lys Tyr Leu Asp Lys Glu Phe Thr 
180 185 190 
Asp Arg Val Glu Gln Asp Phe Val Asp His Gly Ile Lys Met Ala Leu 
195 200 205 
Asn Gln Met Val Gln Gly Phe Ser Asp Asp Gly Lys Glu Val Thr Val 
210 215 220 
Lys Thr Asp Lys Gly Ser Tyr Thr Ala Asp Met Ala Ile Leu Cys Val 
225 230 235 240 
Gly Phe Arg Pro Asn Thr Gly Leu Leu Lys Gly Lys Val Asp Met Asn 
245 250 255 
Ala Asn Gly Ser Ile Lys Thr Asn Asp Tyr Met Gln Thr Ser Asp Pro 
260 265 270 
Asp Ile Tyr Gly Ala Gly Asp Ser Val Ala Val His Tyr Asn Pro Thr 
275 280 285 
Lys Lys Asp Ala Tyr Ile Pro Leu Ala Thr Asn Ala Val Arg Gln Gly 
290 295 300 
Thr Leu Val Gly Leu Asn Ile Phe Lys Pro Thr Arg Lys Tyr Met Gly 
305 310 315 320 
Thr Gln Ser Thr Ser Gly Leu Met Leu Phe Gly Gln Thr Ile Val Ser 
325 330 335 
Ser Gly Met Thr Leu Glu His Ala Gln Ala Glu Asn Val Pro Ala Ala 
340 345 350 
Ala Val Thr Phe Glu Asp Asn Tyr Arg Pro Glu Phe Met Pro Thr Thr 
355 360 365 
Lys Pro Val Leu Met Gln Leu Val Tyr Asn Pro Glu Thr Arg Glu Ile 
370 375 380 
Leu Gly Ala Gln Phe Met Ser Glu His Asp Val Ser Gln Ser Ala Asn 
385 390 395 400 
Val Ile Ser Val Met Ile Gln Asn His Asn Thr Ile Asp Asp Leu Gly 
405 410 415 
Phe Val Asp Met Phe Phe Gln Pro Ile Tyr Asp Arg Pro Phe Asn Tyr 
420 425 430 
Leu Asn Leu Leu Gly Gln Ala Ala Ile Ala His Ala Ala Glu Ala Val 
Thr Glu 
450 
435 440 445 
<210> SEQ ID NO 4 
<211> LENGTH, 450 
<212> TYPE, PRT 
<213> ORGANISM, Lactobacillus plantarum 
32 
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33 
-continued 
<400> SEQUENCE, 4 
Met Lys Val Ile Val Ile Gly Cys Thr His Ala Gly Thr Ala Ala Val 
1 5 10 15 
Asn Gln Ile Leu Ala Ser Asn Pro Asp Thr Glu Val Thr Ile Tyr Glu 
20 25 30 
Arg Asn Asp Asn Val Ser Phe Leu Ser Cys Gly Ile Ala Leu Tyr Leu 
35 40 45 
Gly Gly Gln Val Ala Asp Pro Gln Gly Leu Phe Tyr Ser Ser Pro Glu 
50 55 60 
Gln Leu Ala Lys Leu Gly Ala Thr Val His Met Gln His Asp Val Thr 
65 70 75 80 
Asp Val Asn Thr Asp Lys His Glu Ile Thr Val Thr Asp Leu Lys Thr 
85 90 95 
Gly Glu Ser Lys Thr Asp His Tyr Asp Lys Leu Val Val Thr Thr Gly 
100 105 110 
Ser Trp Pro Val Ile Pro Pro Ile Asp Gly Ile Asp Ser Pro Asn Val 
115 120 125 
Tyr Leu Cys Lys Asn Trp Thr His Ala Gln Asn Leu Trp Glu Ala Ala 
130 135 140 
Lys Pro Ala Lys Arg Val Ile Val Ile Gly Gly Gly Tyr Ile Gly Thr 
145 150 155 160 
Glu Leu Val Glu Ala Tyr Gln Lys Gln Gly Lys Glu Val Thr Leu Ile 
165 170 175 
Asp Lys Leu Pro Arg Ile Leu Asn Lys Tyr Leu Asp Lys Glu Phe Thr 
180 185 190 
Asp Arg Val Glu Gln Asp Phe Val Asp His Gly Ile Lys Met Ala Leu 
195 200 205 
Asn Gln Met Val Gln Gly Phe Ser Asp Asp Gly Lys Glu Val Thr Val 
210 215 220 
Lys Thr Asp Lys Gly Ser Tyr Thr Ala Asp Met Ala Ile Leu Cys Val 
225 230 235 240 
Gly Phe Arg Pro Asn Thr Gly Leu Leu Lys Gly Lys Val Asp Met Asn 
245 250 255 
Ala Asn Gly Ser Ile Lys Thr Asn Asp Tyr Met Gln Thr Ser Asp Pro 
260 265 270 
Asp Ile Tyr Gly Ala Gly Asp Ser Val Ala Val His Tyr Asn Pro Thr 
275 280 285 
Lys Lys Asp Ala Tyr Ile Pro Leu Ala Thr Asn Ala Val Arg Gln Gly 
290 295 300 
Thr Leu Val Gly Leu Asn Ile Phe Lys Pro Thr Arg Lys Tyr Met Gly 
305 310 315 320 
Thr Gln Ser Thr Ser Gly Leu Met Leu Phe Gly Gln Thr Ile Val Ser 
325 330 335 
Ser Gly Met Thr Leu Glu His Ala Gln Ala Glu Asn Val Pro Ala Ala 
340 345 350 
Ala Val Thr Phe Glu Asp Asn Tyr Arg Pro Glu Phe Met Pro Thr Thr 
355 360 365 
Lys Pro Val Leu Met Gln Leu Val Tyr Asn Pro Glu Thr Arg Glu Ile 
370 375 380 
Leu Gly Ala Gln Phe Met Ser Glu His Asp Val Ser Gln Ser Ala Asn 
385 390 395 400 
Val Ile Ser Val Met Ile Gln Asn His Asn Thr Ile Asp Asp Leu Gly 
405 410 415 
34 
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35 
-continued 
Phe Val Asp Met Phe Phe Gln Pro Ile Tyr Asp Arg Pro Phe Asn Tyr 
420 425 430 
Leu Asn Leu Leu Gly Gln Ala Ala Ile Ala His Ala Ala Glu Ala Val 
Thr Glu 
450 
435 440 445 
<210> SEQ ID NO 5 
<211> LENGTH, 1353 
<212> TYPE, DNA 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 5 
atgaaagtta ttgtaattgg ttgtacccat gccggcactg ctgctgttaa tcagatttta 
gcatcaaatc cagatactga agtgacgatt tatgaaagaa atgacaatgt ctcgttccta 
tcctgtggga tcgcacttta ccttggcggc caagttgctg atcctcaagg cctattttat 
tccagtcctg aacagttagc taagttaggc gcaactgttc atatgcaaca tgatgtgacg 
gatgtgaata ctgacaaaca tgaaattacg gttactgact taaagactgg tgaatctaag 
actgatcact atgacaagtt agttgtcact actggttcat ggcctgttat tccaccaatt 
gacggcatcg atagtcccaa tgtctactta tgcaagaact ggacgcacgc tcagaattta 
tgggaagcag ccaaaccagc taagcgggtc attgtgatcg gtggcggtta tatcggtact 
gaattagttg aagcttacca gaagcaaggt aaggaagtca cactaattga tarrttacca 
cggattttaa ataaatactt agacaaagaa ttcactgacc gggttgaaca agactttgtt 
gatcacggta tcaagatggc tttgaatcaa atggtgcaag gcttcagtga tgatggtaaa 
gaagttacgg tcaagactga caagggcagc tacacagccg acatggcgat tctttgtgtt 
ggcttccggc caaataccgg cttactcaag ggcaaggtcg atatgaacgc taatggctcg 
atcaagacca atgactacat gcaaacttct gatccagaca tttacggggc tggtgactcg 
gttgctgttc actataaccc aactaagaaa gatgcttata tcccattagc aacgaatgcg 
gttcgccaag gaaccttagt tggtttgaac atcttcaagc caacgcggaa gtacatgggg 
acacaatcaa cttctgggtt aatgttgttc ggccaaacca tcgtttcatc tgggatgacc 
ctagaacatg cacaggccga aaatgttccg gcagccgctg tcacttttga agacaactac 
cggccagaat ttatgccaac cactaagcct gttttaatgc aattggttta caatcctgaa 
actcgcgaaa tcctaggtgc acaattcatg agtgaacatg atgtttcgca atcagccaat 
gtgatttcag tgatgattca aaatcacaat accattgacg acttagggtt cgtagatatg 
ttcttccaac caatttacga ccggccattt aactatttga acttacttgg tcaagcagcg 
attgcccatg cggccgaagc tgtcactgaa taa 
<210> SEQ ID NO 6 
<211> LENGTH, 450 
<212> TYPE, PRT 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 
Met Lys Val Ile Val Ile Gly Cys Thr His Ala Gly Thr Ala Ala Val 
1 5 10 15 
Asn Gln Ile Leu Ala Ser Asn Pro Asp Thr Glu Val Thr Ile Tyr Glu 
20 25 30 
Arg Asn Asp Asn Val Ser Phe Leu Ser Cys Gly Ile Ala Leu Tyr Leu 
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37 
-continued 
Gly Gly Gln Val Ala Asp Pro Gln Gly Leu Phe Tyr Ser Ser Pro Glu 
50 55 60 
Gln Leu Ala Lys Leu Gly Ala Thr Val His Met Gln His Asp Val Thr 
65 70 75 80 
Asp Val Asn Thr Asp Lys His Glu Ile Thr Val Thr Asp Leu Lys Thr 
85 90 95 
Gly Glu Ser Lys Thr Asp His Tyr Asp Lys Leu Val Val Thr Thr Gly 
100 105 110 
Ser Trp Pro Val Ile Pro Pro Ile Asp Gly Ile Asp Ser Pro Asn Val 
115 120 125 
Tyr Leu Cys Lys Asn Trp Thr His Ala Gln Asn Leu Trp Glu Ala Ala 
130 135 140 
Lys Pro Ala Lys Arg Val Ile Val Ile Gly Gly Gly Tyr Ile Gly Thr 
145 150 155 160 
Glu Leu Val Glu Ala Tyr Gln Lys Gln Gly Lys Glu Val Thr Leu Ile 
165 170 175 
Asp Gly Lys Pro Arg Ile Leu Asn Lys Tyr Leu Asp Lys Glu Phe Thr 
180 185 190 
Asp Arg Val Glu Gln Asp Phe Val Asp His Gly Ile Lys Met Ala Leu 
195 200 205 
Asn Gln Met Val Gln Gly Phe Ser Asp Asp Gly Lys Glu Val Thr Val 
210 215 220 
Lys Thr Asp Lys Gly Ser Tyr Thr Ala Asp Met Ala Ile Leu Cys Val 
225 230 235 240 
Gly Phe Arg Pro Asn Thr Gly Leu Leu Lys Gly Lys Val Asp Met Asn 
245 250 255 
Ala Asn Gly Ser Ile Lys Thr Asn Asp Tyr Met Gln Thr Ser Asp Pro 
260 265 270 
Asp Ile Tyr Gly Ala Gly Asp Ser Val Ala Val His Tyr Asn Pro Thr 
275 280 285 
Lys Lys Asp Ala Tyr Ile Pro Leu Ala Thr Asn Ala Val Arg Gln Gly 
290 295 300 
Thr Leu Val Gly Leu Asn Ile Phe Lys Pro Thr Arg Lys Tyr Met Gly 
305 310 315 320 
Thr Gln Ser Thr Ser Gly Leu Met Leu Phe Gly Gln Thr Ile Val Ser 
325 330 335 
Ser Gly Met Thr Leu Glu His Ala Gln Ala Glu Asn Val Pro Ala Ala 
340 345 350 
Ala Val Thr Phe Glu Asp Asn Tyr Arg Pro Glu Phe Met Pro Thr Thr 
355 360 365 
Lys Pro Val Leu Met Gln Leu Val Tyr Asn Pro Glu Thr Arg Glu Ile 
370 375 380 
Leu Gly Ala Gln Phe Met Ser Glu His Asp Val Ser Gln Ser Ala Asn 
385 390 395 400 
Val Ile Ser Val Met Ile Gln Asn His Asn Thr Ile Asp Asp Leu Gly 
405 410 415 
Phe Val Asp Met Phe Phe Gln Pro Ile Tyr Asp Arg Pro Phe Asn Tyr 
420 425 430 
Leu Asn Leu Leu Gly Gln Ala Ala Ile Ala His Ala Ala Glu Ala Val 
Thr Glu 
450 
435 440 445 
38 
<210> SEQ ID NO 7 
<211> LENGTH, 1353 
<212> TYPE, DNA 
39 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 7 
US 8,530,213 B2 
-continued 
atgaaagtta ttgtaattgg ttgtacccat gccggcactg ctgctgttaa tcagatttta 
gcatcaaatc cagatactga agtgacgatt tatgaaagaa atgacaatgt ctcgttccta 
tcctgtggga tcgcacttta ccttggcggc caagttgctg atcctcaagg cctattttat 
tccagtcctg aacagttagc taagttaggc gcaactgttc atatgcaaca tgatgtgacg 
gatgtgaata ctgacaaaca tgaaattacg gttactgact taaagactgg tgaatctaag 
actgatcact atgacaagtt agttgtcact actggttcat ggcctgttat tccaccaatt 
gacggcatcg atagtcccaa tgtctactta tgcaagaact ggacgcacgc tcagaattta 
tgggaagcag ccaaaccagc taagcgggtc attgtgatcg gtggcggtta tatcggtact 
gaattagttg aagcttacca gaagcaaggt aaggaagtca cactaattga tggtaaacca 
cggattttaa ataaatactt agacaaagaa ttcactgacc gggttgaaca agactttgtt 
gatcacggta tcaagatggc tttgaatcaa atggtgcaag gcttcagtga tgatggtaaa 
gaagttacgg tcaagactga caagggcagc tacacagccg acatggcgat tctttgtgtt 
ggcttccggc caaataccgg cttactcaag ggcaaggtcg atatgaacgc taatggctcg 
atcaagacca atgactacat gcaaacttct gatccagaca tttacggggc tggtgactcg 
gttgctgttc actataaccc aactaagaaa gatgcttata tcccattagc aacgaatgcg 
gttcgccaag gaaccttagt tggtttgaac atcttcaagc caacgcggaa gtacatgggg 
acacaatcaa cttctgggtt aatgttgttc ggccaaacca tcgtttcatc tgggatgacc 
ctagaacatg cacaggccga aaatgttccg gcagccgctg tcacttttga agacaactac 
cggccagaat ttatgccaac cactaagcct gttttaatgc aattggttta caatcctgaa 
actcgcgaaa tcctaggtgc acaattcatg agtgaacatg atgtttcgca atcagccaat 
gtgatttcag tgatgattca aaatcacaat accattgacg acttagggtt cgtagatatg 
ttcttccaac caatttacga ccggccattt aactatttga acttacttgg tcaagcagcg 
attgcccatg cggccgaagc tgtcactgaa taa 
<210> SEQ ID NO 8 
<211> LENGTH, 450 
<212> TYPE, PRT 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 8 
Met Lys Val Ile Val Ile Gly Cys Thr His Ala Gly Thr Ala Ala Val 
1 5 10 15 
Asn Gln Ile Leu Ala Ser Asn Pro Asp Thr Glu Val Thr Ile Tyr Glu 
20 25 30 
Arg Asn Asp Asn Val Ser Phe Leu Ser Cys Gly Ile Ala Leu Tyr Leu 
35 40 45 
Gly Gly Gln Val Ala Asp Pro Gln Gly Leu Phe Tyr Ser Ser Pro Glu 
50 55 60 
Gln Leu Ala Lys Leu Gly Ala Thr Val His Met Gln His Asp Val Thr 
65 70 75 80 
Asp Val Asn Thr Asp Lys His Glu Ile Thr Val Thr Asp Leu Lys Thr 
85 90 95 
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41 
-continued 
100 105 110 
Ser Trp Pro Val Ile Pro Pro Ile Asp Gly Ile Asp Ser Pro Asn Val 
115 120 125 
Tyr Leu Cys Lys Asn Trp Thr His Ala Gln Asn Leu Trp Glu Ala Ala 
130 135 140 
Lys Pro Ala Lys Arg Val Ile Val Ile Gly Gly Gly Tyr Ile Gly Thr 
145 150 155 160 
Glu Leu Val Glu Ala Tyr Gln Lys Gln Gly Lys Glu Val Thr Leu Ile 
165 170 175 
Asp Gly Arg Pro Arg Ile Leu Asn Lys Tyr Leu Asp Lys Glu Phe Thr 
180 185 190 
Asp Arg Val Glu Gln Asp Phe Val Asp His Gly Ile Lys Met Ala Leu 
195 200 205 
Asn Gln Met Val Gln Gly Phe Ser Asp Asp Gly Lys Glu Val Thr Val 
210 215 220 
Lys Thr Asp Lys Gly Ser Tyr Thr Ala Asp Met Ala Ile Leu Cys Val 
225 230 235 240 
Gly Phe Arg Pro Asn Thr Gly Leu Leu Lys Gly Lys Val Asp Met Asn 
245 250 255 
Ala Asn Gly Ser Ile Lys Thr Asn Asp Tyr Met Gln Thr Ser Asp Pro 
260 265 270 
Asp Ile Tyr Gly Ala Gly Asp Ser Val Ala Val His Tyr Asn Pro Thr 
275 280 285 
Lys Lys Asp Ala Tyr Ile Pro Leu Ala Thr Asn Ala Val Arg Gln Gly 
290 295 300 
Thr Leu Val Gly Leu Asn Ile Phe Lys Pro Thr Arg Lys Tyr Met Gly 
305 310 315 320 
Thr Gln Ser Thr Ser Gly Leu Met Leu Phe Gly Gln Thr Ile Val Ser 
325 330 335 
Ser Gly Met Thr Leu Glu His Ala Gln Ala Glu Asn Val Pro Ala Ala 
340 345 350 
Ala Val Thr Phe Glu Asp Asn Tyr Arg Pro Glu Phe Met Pro Thr Thr 
355 360 365 
Lys Pro Val Leu Met Gln Leu Val Tyr Asn Pro Glu Thr Arg Glu Ile 
370 375 380 
Leu Gly Ala Gln Phe Met Ser Glu His Asp Val Ser Gln Ser Ala Asn 
385 390 395 400 
Val Ile Ser Val Met Ile Gln Asn His Asn Thr Ile Asp Asp Leu Gly 
405 410 415 
Phe Val Asp Met Phe Phe Gln Pro Ile Tyr Asp Arg Pro Phe Asn Tyr 
420 425 430 
Leu Asn Leu Leu Gly Gln Ala Ala Ile Ala His Ala Ala Glu Ala Val 
Thr Glu 
450 
435 440 445 
<210> SEQ ID NO 9 
<211> LENGTH, 450 
<212> TYPE, PRT 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 9 
Met Lys Val Ile Val Ile Gly Cys Thr His Ala Gly Thr Ala Ala Val 
1 5 10 15 
Asn Gln Ile Leu Ala Ser Asn Pro Asp Thr Glu Val Thr Ile Tyr Glu 
42 
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43 
-continued 
20 25 30 
Arg Asn Asp Asn Val Ser Phe Leu Ser Cys Gly Ile Ala Leu Tyr Leu 
35 40 45 
Gly Gly Gln Val Ala Asp Pro Gln Gly Leu Phe Tyr Ser Ser Pro Glu 
50 55 60 
Gln Leu Ala Lys Leu Gly Ala Thr Val His Met Gln His Asp Val Thr 
65 70 75 80 
Asp Val Asn Thr Asp Lys His Glu Ile Thr Val Thr Asp Leu Lys Thr 
85 90 95 
Gly Glu Ser Lys Thr Asp His Tyr Asp Lys Leu Val Val Thr Thr Gly 
100 105 110 
Ser Trp Pro Val Ile Pro Pro Ile Asp Gly Ile Asp Ser Pro Asn Val 
115 120 125 
Tyr Leu Cys Lys Asn Trp Thr His Ala Gln Asn Leu Trp Glu Ala Ala 
130 135 140 
Lys Pro Ala Lys Arg Val Ile Val Ile Gly Gly Gly Tyr Ile Gly Thr 
145 150 155 160 
Glu Leu Val Glu Ala Tyr Gln Lys Gln Gly Lys Glu Val Thr Leu Ile 
165 170 175 
Asp Gly His Pro Arg Ile Leu Asn Lys Tyr Leu Asp Lys Glu Phe Thr 
180 185 190 
Asp Arg Val Glu Gln Asp Phe Val Asp His Gly Ile Lys Met Ala Leu 
195 200 205 
Asn Gln Met Val Gln Gly Phe Ser Asp Asp Gly Lys Glu Val Thr Val 
210 215 220 
Lys Thr Asp Lys Gly Ser Tyr Thr Ala Asp Met Ala Ile Leu Cys Val 
225 230 235 240 
Gly Phe Arg Pro Asn Thr Gly Leu Leu Lys Gly Lys Val Asp Met Asn 
245 250 255 
Ala Asn Gly Ser Ile Lys Thr Asn Asp Tyr Met Gln Thr Ser Asp Pro 
260 265 270 
Asp Ile Tyr Gly Ala Gly Asp Ser Val Ala Val His Tyr Asn Pro Thr 
275 280 285 
Lys Lys Asp Ala Tyr Ile Pro Leu Ala Thr Asn Ala Val Arg Gln Gly 
290 295 300 
Thr Leu Val Gly Leu Asn Ile Phe Lys Pro Thr Arg Lys Tyr Met Gly 
305 310 315 320 
Thr Gln Ser Thr Ser Gly Leu Met Leu Phe Gly Gln Thr Ile Val Ser 
325 330 335 
Ser Gly Met Thr Leu Glu His Ala Gln Ala Glu Asn Val Pro Ala Ala 
340 345 350 
Ala Val Thr Phe Glu Asp Asn Tyr Arg Pro Glu Phe Met Pro Thr Thr 
355 360 365 
Lys Pro Val Leu Met Gln Leu Val Tyr Asn Pro Glu Thr Arg Glu Ile 
370 375 380 
Leu Gly Ala Gln Phe Met Ser Glu His Asp Val Ser Gln Ser Ala Asn 
385 390 395 400 
Val Ile Ser Val Met Ile Gln Asn His Asn Thr Ile Asp Asp Leu Gly 
405 410 415 
Phe Val Asp Met Phe Phe Gln Pro Ile Tyr Asp Arg Pro Phe Asn Tyr 
420 425 430 
Leu Asn Leu Leu Gly Gln Ala Ala Ile Ala His Ala Ala Glu Ala Val 




<210> SEQ ID NO 10 
<211> LENGTH, 1353 
<212> TYPE, DNA 
45 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 10 
US 8,530,213 B2 
-continued 
atgaaagtta ttgtaattgg ttgtacccat gccggcactg ctgctgttaa tcagatttta 
gcatcaaatc cagatactga agtgacgatt tatgaaagaa atgacaatgt ctcgttccta 
tcctgtggga tcgcacttta ccttggcggc caagttgctg atcctcaagg cctattttat 
tccagtcctg aacagttagc taagttaggc gcaactgttc atatgcaaca tgatgtgacg 
gatgtgaata ctgacaaaca tgaaattacg gttactgact taaagactgg tgaatctaag 
actgatcact atgacaagtt agttgtcact actggttcat ggcctgttat tccaccaatt 
gacggcatcg atagtcccaa tgtctactta tgcaagaact ggacgcacgc tcagaattta 
tgggaagcag ccaaaccagc taagcgggtc attgtgatcg gtggcggtta tatcggtact 
gaattagttg aagcttacca gaagcaaggt aaggaagtca cactaattga tggtcrycca 
cggattttaa ataaatactt agacaaagaa ttcactgacc gggttgaaca agactttgtt 
gatcacggta tcaagatggc tttgaatcaa atggtgcaag gcttcagtga tgatggtaaa 
gaagttacgg tcaagactga caagggcagc tacacagccg acatggcgat tctttgtgtt 
ggcttccggc caaataccgg cttactcaag ggcaaggtcg atatgaacgc taatggctcg 
atcaagacca atgactacat gcaaacttct gatccagaca tttacggggc tggtgactcg 
gttgctgttc actataaccc aactaagaaa gatgcttata tcccattagc aacgaatgcg 
gttcgccaag gaaccttagt tggtttgaac atcttcaagc caacgcggaa gtacatgggg 
acacaatcaa cttctgggtt aatgttgttc ggccaaacca tcgtttcatc tgggatgacc 
ctagaacatg cacaggccga aaatgttccg gcagccgctg tcacttttga agacaactac 
cggccagaat ttatgccaac cactaagcct gttttaatgc aattggttta caatcctgaa 
actcgcgaaa tcctaggtgc acaattcatg agtgaacatg atgtttcgca atcagccaat 
gtgatttcag tgatgattca aaatcacaat accattgacg acttagggtt cgtagatatg 
ttcttccaac caatttacga ccggccattt aactatttga acttacttgg tcaagcagcg 
attgcccatg cggccgaagc tgtcactgaa taa 
<210> SEQ ID NO 11 
<211> LENGTH, 450 
<212> TYPE, PRT 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 11 
Met Lys Val Ile Val Ile Gly Cys Thr His Ala Gly Thr Ala Ala Val 
1 5 10 15 
Asn Gln Ile Leu Ala Ser Asn Pro Asp Thr Glu Val Thr Ile Tyr Glu 
20 25 30 
Arg Asn Asp Asn Val Ser Phe Leu Ser Cys Gly Ile Ala Leu Tyr Leu 
35 40 45 
Gly Gly Gln Val Ala Asp Pro Gln Gly Leu Phe Tyr Ser Ser Pro Glu 
50 55 60 
Gln Leu Ala Lys Leu Gly Ala Thr Val His Met Gln His Asp Val Thr 
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Asp Val Asn Thr Asp Lys His Glu Ile Thr Val Thr Asp Leu Lys Thr 
85 90 95 
Gly Glu Ser Lys Thr Asp His Tyr Asp Lys Leu Val Val Thr Thr Gly 
100 105 110 
Ser Trp Pro Val Ile Pro Pro Ile Asp Gly Ile Asp Ser Pro Asn Val 
115 120 125 
Tyr Leu Cys Lys Asn Trp Thr His Ala Gln Asn Leu Trp Glu Ala Ala 
130 135 140 
Lys Pro Ala Lys Arg Val Ile Val Ile Gly Gly Gly Tyr Ile Gly Thr 
145 150 155 160 
Glu Leu Val Glu Ala Tyr Gln Lys Gln Gly Lys Glu Val Thr Leu Ile 
165 170 175 
Asp Lys Lys Pro Arg Ile Leu Asn Lys Tyr Leu Asp Lys Glu Phe Thr 
180 185 190 
Asp Arg Val Glu Gln Asp Phe Val Asp His Gly Ile Lys Met Ala Leu 
195 200 205 
Asn Gln Met Val Gln Gly Phe Ser Asp Asp Gly Lys Glu Val Thr Val 
210 215 220 
Lys Thr Asp Lys Gly Ser Tyr Thr Ala Asp Met Ala Ile Leu Cys Val 
225 230 235 240 
Gly Phe Arg Pro Asn Thr Gly Leu Leu Lys Gly Lys Val Asp Met Asn 
245 250 255 
Ala Asn Gly Ser Ile Lys Thr Asn Asp Tyr Met Gln Thr Ser Asp Pro 
260 265 270 
Asp Ile Tyr Gly Ala Gly Asp Ser Val Ala Val His Tyr Asn Pro Thr 
275 280 285 
Lys Lys Asp Ala Tyr Ile Pro Leu Ala Thr Asn Ala Val Arg Gln Gly 
290 295 300 
Thr Leu Val Gly Leu Asn Ile Phe Lys Pro Thr Arg Lys Tyr Met Gly 
305 310 315 320 
Thr Gln Ser Thr Ser Gly Leu Met Leu Phe Gly Gln Thr Ile Val Ser 
325 330 335 
Ser Gly Met Thr Leu Glu His Ala Gln Ala Glu Asn Val Pro Ala Ala 
340 345 350 
Ala Val Thr Phe Glu Asp Asn Tyr Arg Pro Glu Phe Met Pro Thr Thr 
355 360 365 
Lys Pro Val Leu Met Gln Leu Val Tyr Asn Pro Glu Thr Arg Glu Ile 
370 375 380 
Leu Gly Ala Gln Phe Met Ser Glu His Asp Val Ser Gln Ser Ala Asn 
385 390 395 400 
Val Ile Ser Val Met Ile Gln Asn His Asn Thr Ile Asp Asp Leu Gly 
405 410 415 
Phe Val Asp Met Phe Phe Gln Pro Ile Tyr Asp Arg Pro Phe Asn Tyr 
420 425 430 
Leu Asn Leu Leu Gly Gln Ala Ala Ile Ala His Ala Ala Glu Ala Val 
Thr Glu 
450 
435 440 445 
<210> SEQ ID NO 12 
<211> LENGTH, 450 
<212> TYPE, PRT 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 12 
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Met Lys Val Ile Val Ile Gly Cys Thr His Ala Gly Thr Ala Ala Val 
1 5 10 15 
Asn Gln Ile Leu Ala Ser Asn Pro Asp Thr Glu Val Thr Ile Tyr Glu 
20 25 30 
Arg Asn Asp Asn Val Ser Phe Leu Ser Cys Gly Ile Ala Leu Tyr Leu 
35 40 45 
Gly Gly Gln Val Ala Asp Pro Gln Gly Leu Phe Tyr Ser Ser Pro Glu 
50 55 60 
Gln Leu Ala Lys Leu Gly Ala Thr Val His Met Gln His Asp Val Thr 
65 70 75 80 
Asp Val Asn Thr Asp Lys His Glu Ile Thr Val Thr Asp Leu Lys Thr 
85 90 95 
Gly Glu Ser Lys Thr Asp His Tyr Asp Lys Leu Val Val Thr Thr Gly 
100 105 110 
Ser Trp Pro Val Ile Pro Pro Ile Asp Gly Ile Asp Ser Pro Asn Val 
115 120 125 
Tyr Leu Cys Lys Asn Trp Thr His Ala Gln Asn Leu Trp Glu Ala Ala 
130 135 140 
Lys Pro Ala Lys Arg Val Ile Val Ile Gly Gly Gly Tyr Ile Gly Thr 
145 150 155 160 
Glu Leu Val Glu Ala Tyr Gln Lys Gln Gly Lys Glu Val Thr Leu Ile 
165 170 175 
Asp Arg Lys Pro Arg Ile Leu Asn Lys Tyr Leu Asp Lys Glu Phe Thr 
180 185 190 
Asp Arg Val Glu Gln Asp Phe Val Asp His Gly Ile Lys Met Ala Leu 
195 200 205 
Asn Gln Met Val Gln Gly Phe Ser Asp Asp Gly Lys Glu Val Thr Val 
210 215 220 
Lys Thr Asp Lys Gly Ser Tyr Thr Ala Asp Met Ala Ile Leu Cys Val 
225 230 235 240 
Gly Phe Arg Pro Asn Thr Gly Leu Leu Lys Gly Lys Val Asp Met Asn 
245 250 255 
Ala Asn Gly Ser Ile Lys Thr Asn Asp Tyr Met Gln Thr Ser Asp Pro 
260 265 270 
Asp Ile Tyr Gly Ala Gly Asp Ser Val Ala Val His Tyr Asn Pro Thr 
275 280 285 
Lys Lys Asp Ala Tyr Ile Pro Leu Ala Thr Asn Ala Val Arg Gln Gly 
290 295 300 
Thr Leu Val Gly Leu Asn Ile Phe Lys Pro Thr Arg Lys Tyr Met Gly 
305 310 315 320 
Thr Gln Ser Thr Ser Gly Leu Met Leu Phe Gly Gln Thr Ile Val Ser 
325 330 335 
Ser Gly Met Thr Leu Glu His Ala Gln Ala Glu Asn Val Pro Ala Ala 
340 345 350 
Ala Val Thr Phe Glu Asp Asn Tyr Arg Pro Glu Phe Met Pro Thr Thr 
355 360 365 
Lys Pro Val Leu Met Gln Leu Val Tyr Asn Pro Glu Thr Arg Glu Ile 
370 375 380 
Leu Gly Ala Gln Phe Met Ser Glu His Asp Val Ser Gln Ser Ala Asn 
385 390 395 400 
Val Ile Ser Val Met Ile Gln Asn His Asn Thr Ile Asp Asp Leu Gly 
405 410 415 
Phe Val Asp Met Phe Phe Gln Pro Ile Tyr Asp Arg Pro Phe Asn Tyr 
420 425 430 
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Leu Asn Leu Leu Gly Gln Ala Ala Ile Ala His Ala Ala Glu Ala Val 
Thr Glu 
450 
435 440 445 
<210> SEQ ID NO 13 
<211> LENGTH, 1353 
<212> TYPE, DNA 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 13 
atgaaagtta ttgtaattgg ttgtacccat gccggcactg ctgctgttaa tcagatttta 
gcatcaaatc cagatactga agtgacgatt tatgaaagaa atgacaatgt ctcgttccta 
tcctgtggga tcgcacttta ccttggcggc caagttgctg atcctcaagg cctattttat 
tccagtcctg aacagttagc taagttaggc gcaactgttc atatgcaaca tgatgtgacg 
gatgtgaata ctgacaaaca tgaaattacg gttactgact taaagactgg tgaatctaag 
actgatcact atgacaagtt agttgtcact actggttcat ggcctgttat tccaccaatt 
gacggcatcg atagtcccaa tgtctactta tgcaagaact ggacgcacgc tcagaattta 
tgggaagcag ccaaaccagc taagcgggtc attgtgatcg gtggcggtta tatcggtact 
gaattagttg aagcttacca gaagcaaggt aaggaagtca cactaattga tarraaacca 
cggattttaa ataaatactt agacaaagaa ttcactgacc gggttgaaca agactttgtt 
gatcacggta tcaagatggc tttgaatcaa atggtgcaag gcttcagtga tgatggtaaa 
gaagttacgg tcaagactga caagggcagc tacacagccg acatggcgat tctttgtgtt 
ggcttccggc caaataccgg cttactcaag ggcaaggtcg atatgaacgc taatggctcg 
atcaagacca atgactacat gcaaacttct gatccagaca tttacggggc tggtgactcg 
gttgctgttc actataaccc aactaagaaa gatgcttata tcccattagc aacgaatgcg 
gttcgccaag gaaccttagt tggtttgaac atcttcaagc caacgcggaa gtacatgggg 
acacaatcaa cttctgggtt aatgttgttc ggccaaacca tcgtttcatc tgggatgacc 
ctagaacatg cacaggccga aaatgttccg gcagccgctg tcacttttga agacaactac 
cggccagaat ttatgccaac cactaagcct gttttaatgc aattggttta caatcctgaa 
actcgcgaaa tcctaggtgc acaattcatg agtgaacatg atgtttcgca atcagccaat 
gtgatttcag tgatgattca aaatcacaat accattgacg acttagggtt cgtagatatg 
ttcttccaac caatttacga ccggccattt aactatttga acttacttgg tcaagcagcg 
attgcccatg cggccgaagc tgtcactgaa taa 
<210> SEQ ID NO 14 
<211> LENGTH, 450 
<212> TYPE, PRT 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 14 
Met Lys Val Ile Val Ile Gly Cys Thr His Ala Gly Thr Ala Ala Val 
1 5 10 15 
Asn Gln Ile Leu Ala Ser Asn Pro Asp Thr Glu Val Thr Ile Tyr Glu 
20 25 30 
Arg Asn Asp Asn Val Ser Phe Leu Ser Cys Gly Ile Ala Leu Tyr Leu 
35 40 45 
Gly Gly Gln Val Ala Asp Pro Gln Gly Leu Phe Tyr Ser Ser Pro Glu 
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Gln Leu Ala Lys Leu Gly Ala Thr Val His Met Gln His Asp Val Thr 
65 70 75 80 
Asp Val Asn Thr Asp Lys His Glu Ile Thr Val Thr Asp Leu Lys Thr 
85 90 95 
Gly Glu Ser Lys Thr Asp His Tyr Asp Lys Leu Val Val Thr Thr Gly 
100 105 110 
Ser Trp Pro Val Ile Pro Pro Ile Asp Gly Ile Asp Ser Pro Asn Val 
115 120 125 
Tyr Leu Cys Lys Asn Trp Thr His Ala Gln Asn Leu Trp Glu Ala Ala 
130 135 140 
Lys Pro Ala Lys Arg Val Ile Val Ile Gly Gly Gly Tyr Ile Gly Thr 
145 150 155 160 
Glu Leu Val Glu Ala Tyr Gln Lys Gln Gly Lys Glu Val Thr Leu Ile 
165 170 175 
Asp Lys Arg Pro Arg Ile Leu Asn Lys Tyr Leu Asp Lys Glu Phe Thr 
180 185 190 
Asp Arg Val Glu Gln Asp Phe Val Asp His Gly Ile Lys Met Ala Leu 
195 200 205 
Asn Gln Met Val Gln Gly Phe Ser Asp Asp Gly Lys Glu Val Thr Val 
210 215 220 
Lys Thr Asp Lys Gly Ser Tyr Thr Ala Asp Met Ala Ile Leu Cys Val 
225 230 235 240 
Gly Phe Arg Pro Asn Thr Gly Leu Leu Lys Gly Lys Val Asp Met Asn 
245 250 255 
Ala Asn Gly Ser Ile Lys Thr Asn Asp Tyr Met Gln Thr Ser Asp Pro 
260 265 270 
Asp Ile Tyr Gly Ala Gly Asp Ser Val Ala Val His Tyr Asn Pro Thr 
275 280 285 
Lys Lys Asp Ala Tyr Ile Pro Leu Ala Thr Asn Ala Val Arg Gln Gly 
290 295 300 
Thr Leu Val Gly Leu Asn Ile Phe Lys Pro Thr Arg Lys Tyr Met Gly 
305 310 315 320 
Thr Gln Ser Thr Ser Gly Leu Met Leu Phe Gly Gln Thr Ile Val Ser 
325 330 335 
Ser Gly Met Thr Leu Glu His Ala Gln Ala Glu Asn Val Pro Ala Ala 
340 345 350 
Ala Val Thr Phe Glu Asp Asn Tyr Arg Pro Glu Phe Met Pro Thr Thr 
355 360 365 
Lys Pro Val Leu Met Gln Leu Val Tyr Asn Pro Glu Thr Arg Glu Ile 
370 375 380 
Leu Gly Ala Gln Phe Met Ser Glu His Asp Val Ser Gln Ser Ala Asn 
385 390 395 400 
Val Ile Ser Val Met Ile Gln Asn His Asn Thr Ile Asp Asp Leu Gly 
405 410 415 
Phe Val Asp Met Phe Phe Gln Pro Ile Tyr Asp Arg Pro Phe Asn Tyr 
420 425 430 
Leu Asn Leu Leu Gly Gln Ala Ala Ile Ala His Ala Ala Glu Ala Val 
Thr Glu 
450 
435 440 445 
<210> SEQ ID NO 15 
<211> LENGTH, 450 
<212> TYPE, PRT 
54 
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<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 15 
Met Lys Val Ile Val Ile Gly Cys Thr His Ala Gly Thr Ala Ala Val 
1 5 10 15 
Asn Gln Ile Leu Ala Ser Asn Pro Asp Thr Glu Val Thr Ile Tyr Glu 
20 25 30 
Arg Asn Asp Asn Val Ser Phe Leu Ser Cys Gly Ile Ala Leu Tyr Leu 
35 40 45 
Gly Gly Gln Val Ala Asp Pro Gln Gly Leu Phe Tyr Ser Ser Pro Glu 
50 55 60 
Gln Leu Ala Lys Leu Gly Ala Thr Val His Met Gln His Asp Val Thr 
65 70 75 80 
Asp Val Asn Thr Asp Lys His Glu Ile Thr Val Thr Asp Leu Lys Thr 
85 90 95 
Gly Glu Ser Lys Thr Asp His Tyr Asp Lys Leu Val Val Thr Thr Gly 
100 105 110 
Ser Trp Pro Val Ile Pro Pro Ile Asp Gly Ile Asp Ser Pro Asn Val 
115 120 125 
Tyr Leu Cys Lys Asn Trp Thr His Ala Gln Asn Leu Trp Glu Ala Ala 
130 135 140 
Lys Pro Ala Lys Arg Val Ile Val Ile Gly Gly Gly Tyr Ile Gly Thr 
145 150 155 160 
Glu Leu Val Glu Ala Tyr Gln Lys Gln Gly Lys Glu Val Thr Leu Ile 
165 170 175 
Asp Lys His Pro Arg Ile Leu Asn Lys Tyr Leu Asp Lys Glu Phe Thr 
180 185 190 
Asp Arg Val Glu Gln Asp Phe Val Asp His Gly Ile Lys Met Ala Leu 
195 200 205 
Asn Gln Met Val Gln Gly Phe Ser Asp Asp Gly Lys Glu Val Thr Val 
210 215 220 
Lys Thr Asp Lys Gly Ser Tyr Thr Ala Asp Met Ala Ile Leu Cys Val 
225 230 235 240 
Gly Phe Arg Pro Asn Thr Gly Leu Leu Lys Gly Lys Val Asp Met Asn 
245 250 255 
Ala Asn Gly Ser Ile Lys Thr Asn Asp Tyr Met Gln Thr Ser Asp Pro 
260 265 270 
Asp Ile Tyr Gly Ala Gly Asp Ser Val Ala Val His Tyr Asn Pro Thr 
275 280 285 
Lys Lys Asp Ala Tyr Ile Pro Leu Ala Thr Asn Ala Val Arg Gln Gly 
290 295 300 
Thr Leu Val Gly Leu Asn Ile Phe Lys Pro Thr Arg Lys Tyr Met Gly 
305 310 315 320 
Thr Gln Ser Thr Ser Gly Leu Met Leu Phe Gly Gln Thr Ile Val Ser 
325 330 335 
Ser Gly Met Thr Leu Glu His Ala Gln Ala Glu Asn Val Pro Ala Ala 
340 345 350 
Ala Val Thr Phe Glu Asp Asn Tyr Arg Pro Glu Phe Met Pro Thr Thr 
355 360 365 
Lys Pro Val Leu Met Gln Leu Val Tyr Asn Pro Glu Thr Arg Glu Ile 
370 375 380 
Leu Gly Ala Gln Phe Met Ser Glu His Asp Val Ser Gln Ser Ala Asn 
385 390 395 400 
Val Ile Ser Val Met Ile Gln Asn His Asn Thr Ile Asp Asp Leu Gly 
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405 410 415 
Phe Val Asp Met Phe Phe Gln Pro Ile Tyr Asp Arg Pro Phe Asn Tyr 
420 425 430 
Leu Asn Leu Leu Gly Gln Ala Ala Ile Ala His Ala Ala Glu Ala Val 
Thr Glu 
450 
435 440 445 
<210> SEQ ID NO 16 
<211> LENGTH, 450 
<212> TYPE, PRT 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 16 
Met Lys Val Ile Val Ile Gly Cys Thr His Ala Gly Thr Ala Ala Val 
1 5 10 15 
Asn Gln Ile Leu Ala Ser Asn Pro Asp Thr Glu Val Thr Ile Tyr Glu 
20 25 30 
Arg Asn Asp Asn Val Ser Phe Leu Ser Cys Gly Ile Ala Leu Tyr Leu 
35 40 45 
Gly Gly Gln Val Ala Asp Pro Gln Gly Leu Phe Tyr Ser Ser Pro Glu 
50 55 60 
Gln Leu Ala Lys Leu Gly Ala Thr Val His Met Gln His Asp Val Thr 
65 70 75 80 
Asp Val Asn Thr Asp Lys His Glu Ile Thr Val Thr Asp Leu Lys Thr 
85 90 95 
Gly Glu Ser Lys Thr Asp His Tyr Asp Lys Leu Val Val Thr Thr Gly 
100 105 110 
Ser Trp Pro Val Ile Pro Pro Ile Asp Gly Ile Asp Ser Pro Asn Val 
115 120 125 
Tyr Leu Cys Lys Asn Trp Thr His Ala Gln Asn Leu Trp Glu Ala Ala 
130 135 140 
Lys Pro Ala Lys Arg Val Ile Val Ile Gly Gly Gly Tyr Ile Gly Thr 
145 150 155 160 
Glu Leu Val Glu Ala Tyr Gln Lys Gln Gly Lys Glu Val Thr Leu Ile 
165 170 175 
Asp Arg Arg Pro Arg Ile Leu Asn Lys Tyr Leu Asp Lys Glu Phe Thr 
180 185 190 
Asp Arg Val Glu Gln Asp Phe Val Asp His Gly Ile Lys Met Ala Leu 
195 200 205 
Asn Gln Met Val Gln Gly Phe Ser Asp Asp Gly Lys Glu Val Thr Val 
210 215 220 
Lys Thr Asp Lys Gly Ser Tyr Thr Ala Asp Met Ala Ile Leu Cys Val 
225 230 235 240 
Gly Phe Arg Pro Asn Thr Gly Leu Leu Lys Gly Lys Val Asp Met Asn 
245 250 255 
Ala Asn Gly Ser Ile Lys Thr Asn Asp Tyr Met Gln Thr Ser Asp Pro 
260 265 270 
Asp Ile Tyr Gly Ala Gly Asp Ser Val Ala Val His Tyr Asn Pro Thr 
275 280 285 
Lys Lys Asp Ala Tyr Ile Pro Leu Ala Thr Asn Ala Val Arg Gln Gly 
290 295 300 
Thr Leu Val Gly Leu Asn Ile Phe Lys Pro Thr Arg Lys Tyr Met Gly 
305 310 315 320 
Thr Gln Ser Thr Ser Gly Leu Met Leu Phe Gly Gln Thr Ile Val Ser 
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325 330 335 
Ser Gly Met Thr Leu Glu His Ala Gln Ala Glu Asn Val Pro Ala Ala 
340 345 350 
Ala Val Thr Phe Glu Asp Asn Tyr Arg Pro Glu Phe Met Pro Thr Thr 
355 360 365 
Lys Pro Val Leu Met Gln Leu Val Tyr Asn Pro Glu Thr Arg Glu Ile 
370 375 380 
Leu Gly Ala Gln Phe Met Ser Glu His Asp Val Ser Gln Ser Ala Asn 
385 390 395 400 
Val Ile Ser Val Met Ile Gln Asn His Asn Thr Ile Asp Asp Leu Gly 
405 410 415 
Phe Val Asp Met Phe Phe Gln Pro Ile Tyr Asp Arg Pro Phe Asn Tyr 
420 425 430 
Leu Asn Leu Leu Gly Gln Ala Ala Ile Ala His Ala Ala Glu Ala Val 
Thr Glu 
450 
435 440 445 
<210> SEQ ID NO 17 
<211> LENGTH, 450 
<212> TYPE, PRT 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 17 
Met Lys Val Ile Val Ile Gly Cys Thr His Ala Gly Thr Ala Ala Val 
1 5 10 15 
Asn Gln Ile Leu Ala Ser Asn Pro Asp Thr Glu Val Thr Ile Tyr Glu 
20 25 30 
Arg Asn Asp Asn Val Ser Phe Leu Ser Cys Gly Ile Ala Leu Tyr Leu 
35 40 45 
Gly Gly Gln Val Ala Asp Pro Gln Gly Leu Phe Tyr Ser Ser Pro Glu 
50 55 60 
Gln Leu Ala Lys Leu Gly Ala Thr Val His Met Gln His Asp Val Thr 
65 70 75 80 
Asp Val Asn Thr Asp Lys His Glu Ile Thr Val Thr Asp Leu Lys Thr 
85 90 95 
Gly Glu Ser Lys Thr Asp His Tyr Asp Lys Leu Val Val Thr Thr Gly 
100 105 110 
Ser Trp Pro Val Ile Pro Pro Ile Asp Gly Ile Asp Ser Pro Asn Val 
115 120 125 
Tyr Leu Cys Lys Asn Trp Thr His Ala Gln Asn Leu Trp Glu Ala Ala 
130 135 140 
Lys Pro Ala Lys Arg Val Ile Val Ile Gly Gly Gly Tyr Ile Gly Thr 
145 150 155 160 
Glu Leu Val Glu Ala Tyr Gln Lys Gln Gly Lys Glu Val Thr Leu Ile 
165 170 175 
Asp Arg His Pro Arg Ile Leu Asn Lys Tyr Leu Asp Lys Glu Phe Thr 
180 185 190 
Asp Arg Val Glu Gln Asp Phe Val Asp His Gly Ile Lys Met Ala Leu 
195 200 205 
Asn Gln Met Val Gln Gly Phe Ser Asp Asp Gly Lys Glu Val Thr Val 
210 215 220 
Lys Thr Asp Lys Gly Ser Tyr Thr Ala Asp Met Ala Ile Leu Cys Val 
225 230 235 240 
Gly Phe Arg Pro Asn Thr Gly Leu Leu Lys Gly Lys Val Asp Met Asn 
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245 250 255 
Ala Asn Gly Ser Ile Lys Thr Asn Asp Tyr Met Gln Thr Ser Asp Pro 
260 265 270 
Asp Ile Tyr Gly Ala Gly Asp Ser Val Ala Val His Tyr Asn Pro Thr 
275 280 285 
Lys Lys Asp Ala Tyr Ile Pro Leu Ala Thr Asn Ala Val Arg Gln Gly 
290 295 300 
Thr Leu Val Gly Leu Asn Ile Phe Lys Pro Thr Arg Lys Tyr Met Gly 
305 310 315 320 
Thr Gln Ser Thr Ser Gly Leu Met Leu Phe Gly Gln Thr Ile Val Ser 
325 330 335 
Ser Gly Met Thr Leu Glu His Ala Gln Ala Glu Asn Val Pro Ala Ala 
340 345 350 
Ala Val Thr Phe Glu Asp Asn Tyr Arg Pro Glu Phe Met Pro Thr Thr 
355 360 365 
Lys Pro Val Leu Met Gln Leu Val Tyr Asn Pro Glu Thr Arg Glu Ile 
370 375 380 
Leu Gly Ala Gln Phe Met Ser Glu His Asp Val Ser Gln Ser Ala Asn 
385 390 395 400 
Val Ile Ser Val Met Ile Gln Asn His Asn Thr Ile Asp Asp Leu Gly 
405 410 415 
Phe Val Asp Met Phe Phe Gln Pro Ile Tyr Asp Arg Pro Phe Asn Tyr 
420 425 430 
Leu Asn Leu Leu Gly Gln Ala Ala Ile Ala His Ala Ala Glu Ala Val 
Thr Glu 
450 
435 440 445 
<210> SEQ ID NO 18 
<211> LENGTH, 1353 
<212> TYPE, DNA 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 18 
atgaaagtta ttgtaattgg ttgtacccat gccggcactg ctgctgttaa tcagatttta 60 
gcatcaaatc cagatactga agtgacgatt tatgaaagaa atgacaatgt ctcgttccta 120 
tcctgtggga tcgcacttta ccttggcggc caagttgctg atcctcaagg cctattttat 180 
tccagtcctg aacagttagc taagttaggc gcaactgttc atatgcaaca tgatgtgacg 240 
gatgtgaata ctgacaaaca tgaaattacg gttactgact taaagactgg tgaatctaag 300 
actgatcact atgacaagtt agttgtcact actggttcat ggcctgttat tccaccaatt 360 
gacggcatcg atagtcccaa tgtctactta tgcaagaact ggacgcacgc tcagaattta 420 
tgggaagcag ccaaaccagc taagcgggtc attgtgatcg gtggcggtta tatcggtact 480 
gaattagttg aagcttacca gaagcaaggt aaggaagtca cactaattga tarrcrycca 540 
cggattttaa ataaatactt agacaaagaa ttcactgacc gggttgaaca agactttgtt 600 
gatcacggta tcaagatggc tttgaatcaa atggtgcaag gcttcagtga tgatggtaaa 660 
gaagttacgg tcaagactga caagggcagc tacacagccg acatggcgat tctttgtgtt 720 
ggcttccggc caaataccgg cttactcaag ggcaaggtcg atatgaacgc taatggctcg 780 
atcaagacca atgactacat gcaaacttct gatccagaca tttacggggc tggtgactcg 840 
gttgctgttc actataaccc aactaagaaa gatgcttata tcccattagc aacgaatgcg 900 









<210> SEQ ID NO 19 
<211> LENGTH, 47 









<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 19 








tgcatgcatg ccatggttat gaaagttatt gtaattggtt gtaccca 
<210> SEQ ID NO 20 
<211> LENGTH, 40 
<212> TYPE, DNA 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 20 
ccgccgccgc cgctcgagtt attcagtgac agcttcggcc 
<210> SEQ ID NO 21 
<211> LENGTH, 63 
<212> TYPE, DNA 
<213> ORGANISM, Lactobacillus plantarum 










gcaaggtaag gaagtcacac taattgatar rttaccacgg attttaaata aatacttaga 60 
caa 63 
<210> SEQ ID NO 22 
<211> LENGTH, 62 
<212> TYPE, DNA 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 22 
aggtaaggaa gtcacactaa ttgatggtcr yccacggatt ttaaataaat acttagacaa 60 
ag 62 
<210> SEQ ID NO 23 
<211> LENGTH, 61 
<212> TYPE, DNA 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 23 
aggtaaggaa gtcacactaa ttgatggtaa accacggatt ttaaataaat acttagacaa 60 
a 61 
<210> SEQ ID NO 24 
<211> LENGTH, 65 
<212> TYPE, DNA 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 24 
gcaaggtaag gaagtcacac taattgatar rcryccacgg attttaaata aatacttaga 60 
64 




<210> SEQ ID NO 25 
<211> LENGTH, 64 
<212> TYPE, DNA 
<213> ORGANISM, Lactobacillus plantarum 
<400> SEQUENCE, 25 
65 
gcaaggtaag gaagtcacac taattgatar raaaccacgg attttaaata aatacttaga 60 
caaa 64 
What is claimed is: 
1. An isolated bacterial NADH oxidase, which is obtained 




at least one amino acid mutation that facilitates enzymatic 
activity towards NADPH and comprises an amino acid 
sequence selected from the group consisting of SEQ ID 
NO: 3, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, 
SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 12, SEQ 25 
ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, and SEQ 
IDNO: 17. 
2. The isolated bacterial NADH oxidase of claim 1, 
encoded by a nucleic acid sequence, which hybridizes under 
stringent conditions to the nucleic acid selected from the 30 
group consisting of SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID 
NO: 10, SEQ ID NO: 13, and SEQ ID NO: 18. 
3. The isolated bacterial NADH oxidase of claim 1, which 
comprises SEQ ID NO: 8. 
4. The isolated bacterial NADH oxidase of claim 3, 35 
encoded by a nucleic acid sequence comprising SEQ ID NO: 
oxidizing the reduced nicotinamide-based cofactor with a 
second enzyme selective for a nicotinamide-based 
cofactor, 
wherein the second enzyme selective for a nicotinamide-
based cofactor comprises an amino acid sequence 
selected from the group consisting of SEQ ID NO: 3, 
SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID 
NO: 9, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 
14, SEQ ID NO: 15, SEQ ID NO: 16, or SEQ ID NO: 17. 
8. The method of producing an enantiomer-enriched 
organic compound of claim 7, wherein the enantiomer com-
prises an L-nucleoside, and wherein the second enzyme 
selective for a nicotinamide-based cofactor comprises a 
NADH oxidase obtained from Lactobacillus plantarum. 
9. The method of producing an enantiomer-enriched 
organic compound of claim 7, wherein the second enzyme 
selective for a nicotinamide-based cofactor can oxidize 
NADPH and NADH. 
10. The method of producing an enantiomer-enriched 
organic compound of claim 9, wherein the second enzyme 
selective for a nicotinamide-based cofactor comprises SEQ 
IDNO: 8. 
10. 
5. The isolated bacterial NADH oxidase of claim 1, which 
comprises SEQ ID NO: 16. 
6. The isolated bacterial NADH oxidase of claim 5, 
encoded by a nucleic acid sequence comprising SEQ ID NO: 
11. The method of producing an enantiomer-enriched 
organic compound of claim 9, wherein the second enzyme 
selective for a nicotinamide-based cofactor comprises SEQ 
40 ID NO: 18. 
18. 
7. A method of producing an enantiomer-enriched organic 
compound, comprising: 
reacting a substrate with a first enzyme selective for pro- 45 
ducing an enantiomer, wherein the first enzyme requires 
a oxidized nicotinamide-based cofactor for catalytic 
activity; 
producing the enantiomer, its oxidized counterpart, and a 
reduced nicotinamide-based cofactor; and 
12. The method of producing an enantiomer-enriched 
organic compound of claim 7, wherein the second enzyme 
selective for a nicotinamide-based cofactor can catalyze more 
than 113,000 turnovers per active site. 
13. The method of producing an enantiomer-enriched 
organic compound of claim 7, wherein the second enzyme 
selective for a nicotinamide-based cofactor can catalyze more 
than 100,000 turnovers per active site in the absence of an 
externally added reducing agent. 
* * * * * 
